info icon

Parodontitis, under 40 years, or operation codes

K11_PARODON_OPER_EARLY

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Pre-conditions: EVENT_AGE<40

Registry filters:

0 out of 7 registries used, show all original rules.

0

4. Check minimum number of events

None

0

5. Include endpoints

4561

6. Filter based on genotype QC (FinnGen only)

4561

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF7

Case counts by codes

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 4561 2815 1746
Unadjusted period prevalence (%) 0.89 0.96 0.77
Median age at first event (years) 33.31 32.84 34.06

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
3785
Matched controls
37850
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K05.30
ICD-10 Finland
Periodontitis complex
446.8
323.0
2926
288
K05.31
ICD-10 Finland
Periodontitis pronounced
110.3
323.0
1243
167
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
4.8
323.0
1721
5642
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
3.8
316.2
2174
9990
SAA02
NOMESCO Finland
Basic examination of mouth
4.5
261.3
3335
23471
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
3.1
235.6
2194
11625
K02.1
ICD-10 Finland
Caries of dentine
3.4
227.8
3023
20288
WX110
NOMESCO Finland
Local anesthesy
3.5
206.9
3189
22829
SDA05
NOMESCO Finland
Very demanding and lengthy parodonthologic therapy
7.0
192.9
513
828
SAA01
NOMESCO Finland
Simple examination of mouth
3.2
171.7
3221
24155
EB1AA
NOMESCO Finland
Tooth X-ray examination
2.6
170.2
2466
15717
SAA03
NOMESCO Finland
Extended examination of mouth
2.6
169.2
2096
12207
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
2.8
166.9
2905
20483
WX290
NOMESCO Finland
Other blockade of nerve
2.6
165.6
2584
17041
SDA02
NOMESCO Finland
Parodonthologic therapy
2.6
154.1
1676
8907
EBA00
NOMESCO Finland
Extraction of tooth
2.5
142.8
1730
9623
SDA12
NOMESCO Finland
Treatment of complicated periodontal disease
78.7
133.5
151
20
SFA10
NOMESCO Finland
Fillning on one surface of tooth
2.4
132.6
2483
16942
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
2.3
128.8
2589
18157
WZA90
NOMESCO Finland
Other doctors statement
2.6
127.6
1255
6140
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
3.9
123.0
557
1586
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
2.7
121.5
1006
4434
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
2.4
103.4
1143
5814
SDE04
NOMESCO Finland
Periodontal treatment by dental hygienist, very extensive
3.5
103.1
544
1742
K05.3
ICD-10 Finland
Chronic periodontitis
8.9
99.0
220
262
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.1
92.7
1489
8902
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.5
91.1
868
4045
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.1
89.5
1321
7586
SBA00
NOMESCO Finland
Microbiological examinations
11.6
89.4
171
154
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.9
83.7
2062
14399
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
2.0
80.3
1325
7882
SDA
NOMESCO Finland
Treatment of periodontitis and gingival lesions
65.2
71.7
83
13
D82
ICPC
Teeth/gum disease
1.9
71.1
1695
11431
KMAK
NOMESCO Finland
NA
1.8
67.5
2434
18742
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.8
66.9
480
1868
-1
NOMESCO Finland
NA
1.8
66.4
1639
11099
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
2.1
65.3
954
5311
EBA05
NOMESCO Finland
Complicated extraction of tooth
2.2
64.1
771
3940
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.8
57.5
1394
9248
K05.4
ICD-10 Finland
Periodontosis
152.4
57.0
60
*
K05.38
ICD-10 Finland
Other chronic periodontitis
12.8
55.4
100
80
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
4.2
54.3
220
553
SGA01
NOMESCO Finland
Tooth opening as first aid
2.0
53.7
816
4558
SAAPA
NOMESCO Finland
NA
23.1
53.2
77
34
EBA15
NOMESCO Finland
Extraction of large number of teeth
7.1
51.7
130
188
D19
ICPC
Teeth/gum symptom/complaint
1.8
50.7
1123
7161
Z01.2
ICD-10 Finland
Dental examination
1.7
50.3
1712
12439
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.7
49.5
1293
8670
EBA10
NOMESCO Finland
Surgical removal of tooth
1.9
49.3
923
5549
K02.0
ICD-10 Finland
Caries limited to enamel
1.9
47.0
854
5068
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.7
46.2
216
616
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
2.0
45.0
654
3559
C03CA01
ATC
furosemide; systemic
3.4
44.7
230
707
SAA04
NOMESCO Finland
Special inverstigation of mouth
3.0
43.0
261
902
SGB10
NOMESCO Finland
Fiiling of rooth of tooth with one root channel
2.3
42.7
430
1991
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
7.9
42.0
98
127
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
2.1
41.6
506
2554
ECA50
NOMESCO Finland
Parodontal operation
31.0
41.4
55
18
Z94.0
ICD-10 Finland
Kidney transplant status
9.6
41.1
85
90
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
7.6
40.7
97
130
K04.1
ICD-10 Finland
Necrosis of pulp
2.2
40.5
448
2167
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
2.6
40.3
315
1275
127
Kela drug reimbursment
Transplant complication
7.1
39.5
99
143
SPAT1283
SPAT
Restricted health certificate
1.6
39.3
1254
8768
K04.0
ICD-10 Finland
Pulpitis
2.0
38.7
564
3057
L04AA06
ATC
mycophenolic acid; systemic
6.3
38.6
105
170
A11CC03
ATC
alfacalcidol; systemic
6.9
38.3
98
146
P01AB01
ATC
metronidazole; oral, rectal
1.6
38.2
1225
8559
TK800
NOMESCO Finland
Hemodialysis
6.8
36.3
93
139
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
11.2
35.1
67
61
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
8.6
35.0
77
91
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
3.3
34.6
184
580
SFA40
NOMESCO Finland
Replacement of krone of tooth
2.1
33.7
424
2160
EMAK
NOMESCO Finland
NA
2.8
33.6
221
806
A12AA04
ATC
calcium carbonate; oral
9.9
33.5
68
70
K05.39
ICD-10 Finland
Periodontitis UNS
7.8
33.1
77
100
SGC10
NOMESCO Finland
Covering pulpa of tooth
1.9
33.0
552
3135
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
2.2
32.9
349
1647
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.6
31.9
988
6771
SPAT1310
SPAT
Counselling related to known health issue
1.6
31.8
1124
7967
K03.66
ICD-10 Finland
Tooth plaque
2.6
31.2
233
917
N07BA03
ATC
varenicline; oral
2.6
30.4
234
935
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
12.4
30.0
54
44
SDA10
NOMESCO Finland
Parodonthologic therapy of advnaced and complicated changes of alveolar bone
41.4
29.9
37
9
SDA13
NOMESCO Finland
Treatment of complicated periodontal disease, extensive and demanding
68.5
29.9
34
5
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.6
29.8
1075
7629
SGA03
NOMESCO Finland
Demanding opening and dilatation of root canal of tooth
2.0
29.8
435
2346
ECA55
NOMESCO Finland
Complicated parodontal operation
25.9
29.7
41
16
SPAT1263
SPAT
Sampling
1.5
29.5
1579
12258
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
29.4
843
5638
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
9.4
29.3
61
66
K04.7
ICD-10 Finland
Periapical abscess without sinus
2.8
29.3
199
740
Z49.0
ICD-10 Finland
Preparatory care for dialysis
12.8
29.3
52
41
SGC00
NOMESCO Finland
Local medication of root channels of tooth
1.9
29.0
477
2686
EB1CA
NOMESCO Finland
Tooth X-ray additional picture
2.0
29.0
387
2014
K08.3
ICD-10 Finland
Retained dental root
2.9
28.9
179
628
B05DA
ATC
Isotonic solutions
11.9
28.9
53
45
N05AH04
ATC
quetiapine; oral
1.7
28.9
747
4856
B03XA02
ATC
darbepoetin alfa; parenteral
8.1
28.8
65
81
137
Kela drug reimbursment
Uraemia requiring dialysis
10.0
28.4
57
58
Z3231
NOMESCO Finland
Registered nurse
1.7
28.3
760
4986
K04.08
ICD-10 Finland
Other specified pulpit
2.0
27.9
373
1939
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
5.7
27.9
81
144
HMAK
NOMESCO Finland
NA
1.8
27.7
563
3401
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.3
27.3
256
1136
N02BE01
ATC
paracetamol; systemic, rectal
1.5
27.3
2737
24033
Z49.2
ICD-10 Finland
Other dialysis
11.8
27.1
50
43
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.4
27.1
135
406
SPAT1312
SPAT
General health counselling
1.5
25.8
1257
9481
Z49.1
ICD-10 Finland
Extracorporeal dialysis
7.3
25.7
62
86
205
Kela drug reimbursment
Chronic hypertension
3.1
25.6
143
469
SGA04
NOMESCO Finland
Very demanding opening and dilatation of root canal of tooth
1.8
25.4
502
2997
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.3
25.4
241
1075
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.9
25.3
423
2387
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
10.5
25.2
49
47
SPAT1301
SPAT
No procedures
1.5
24.9
996
7186
C08CA01
ATC
amlodipine; oral
2.1
24.8
283
1376
A03
ICPC
Fever
1.6
24.7
847
5892
K03.64
ICD-10 Finland
Dental calculus supragingival
1.5
24.7
1211
9125
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.9
24.7
391
2166
TK820
NOMESCO Finland
Peritoneal dialysis
14.3
24.3
41
29
103
Kela drug reimbursment
Diabetes, insulin-treated
1.9
24.2
394
2205
S18
ICPC
Laceration/cut
1.5
24.2
970
6991
N06AB04
ATC
citalopram; systemic
1.7
24.0
630
4085
ECA70
NOMESCO Finland
Regenerative parodontal operation or gingiva and alveolus transplantation
17.8
23.9
37
21
N18.0
ICD-10 Finland
End-stage renal disease
9.2
23.5
49
54
K06.18
ICD-10 Finland
Another gingival hyperplasia
18.2
23.5
36
20
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.1
23.4
129
420
SPAT1262
SPAT
Handing over of treatment supplies
1.9
23.2
378
2115
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
22.8
692
4656
WX002
NOMESCO Finland
Sedation and analgesia
1.8
22.8
391
2226
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
11.5
22.6
42
37
N07BB01
ATC
disulfiram; oral
2.5
22.6
179
728
V03AE02
ATC
sevelamer; oral
11.8
22.4
41
35
SGA05
NOMESCO Finland
Very demanding and lengthy opening and dilatation of root canal of tooth
2.0
22.3
304
1592
Z72.0
ICD-10 Finland
Tobacco use
3.3
22.3
113
346
R74
ICPC
Upper respiratory infection acute
1.4
22.2
1457
11572
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.7
22.0
539
3427
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
1.7
21.7
494
3070
SGB30
NOMESCO Finland
Other demanding filling of root channel of tooth
1.7
21.6
537
3422
SPAT1216
SPAT
Assessment of functional ability
2.2
21.6
238
1142
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
8.6
21.3
46
54
Z3229
NOMESCO Finland
Other healthcare associate professional
2.3
21.3
211
963
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
21.2
488
3044
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.9
21.2
330
1814
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.6
21.1
609
4040
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
3.0
21.1
123
417
B05DB
ATC
Hypertonic solutions
10.1
20.8
41
41
A10AE04
ATC
insulin glargine; parenteral
2.1
20.7
257
1296
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
3.0
20.7
120
405
WZA00
NOMESCO Finland
Short statement of of health and health related matters
2.0
20.6
275
1429
K05.32
ICD-10 Finland
Periodontitis NOS
1.6
20.6
588
3889
Z2446
NOMESCO Finland
Social worker
2.0
20.5
261
1329
K05.18
ICD-10 Finland
Chronic gingivitis
2.2
20.5
227
1089
WKPAL
NOMESCO Finland
NA
3.9
20.2
83
214
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.9
20.1
336
1893
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.1
20.1
234
1149
M54.5
ICD-10 Finland
Low back pain
1.4
19.7
1063
8086
D11
ICPC
Diarrhoea
1.6
19.4
545
3581
SPAT1254
SPAT
Administration of medicine
1.7
19.4
388
2319
D10
ICPC
Vomiting
1.7
19.4
391
2343
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
3.4
19.2
94
281
SPAT1240
SPAT
Therapeutic discussion
1.6
19.1
609
4132
A02BC02
ATC
pantoprazole; systemic
1.4
19.1
1553
12703
N18.8
ICD-10 Finland
Other chronic renal failure
5.4
19.0
57
107
C09AA02
ATC
enalapril; systemic
2.3
18.9
179
800
N01
ICPC
Headache
1.6
18.8
518
3385
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.8
18.8
364
2154
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
5.1
18.8
59
117
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
18.6
520
3415
SPAT1260
SPAT
Consultation of another employee
1.6
18.4
519
3413
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
18.4
1250
9896
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
2.2
18.3
191
893
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
3.8
18.3
78
209
V03AE01
ATC
polystyrene sulfonate; oral
8.6
18.1
39
46
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
4.4
17.9
64
146
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
5.5
17.8
52
95
O04.9
ICD-10 Finland
Medical abortion, complete or unspecified, without complication
1.6
17.6
507
3347
SFC92
NOMESCO Finland
Other demanding adjuvant procedure of filling therapy
2.4
17.6
146
611
SGB20
NOMESCO Finland
Filling of root of tooth with 2 root channels
1.9
17.5
279
1546
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.9
17.4
271
1489
C10AA01
ATC
simvastatin; oral
2.1
17.3
193
930
S10
ICPC
Boil/carbuncle
2.1
17.3
189
905
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
11.1
17.2
32
29
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
3.3
17.2
86
263
K05.20
ICD-10 Finland
Periodontal abscess without fistula
6.7
17.0
43
65
K10.3
ICD-10 Finland
Alveolitis of jaws
2.0
16.9
221
1136
SDC10
NOMESCO Finland
Parodontological fixation
17.4
16.9
26
15
L17
ICPC
Foot/toe symptom/complaint
1.5
16.6
594
4128
K06.19
ICD-10 Finland
Gingival hyperplasia UNS
12.7
16.6
29
23
N05AH03
ATC
olanzapine; systemic
1.8
16.5
287
1638
N06AX21
ATC
duloxetine; oral
1.8
16.4
301
1746
ZX120
NOMESCO Finland
Intravenous
2.0
16.4
205
1039
M79.6
ICD-10 Finland
Pain in limb
1.4
16.3
917
6986
SXA20
NOMESCO Finland
Local application of medicine to mouth
1.8
16.3
293
1692
J01CE02
ATC
phenoxymethylpenicillin; oral
1.4
16.2
2794
25457
R05
ICPC
Cough
1.5
16.1
693
5013
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
1.9
16.0
250
1376
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
16.0
1418
11661
ZXE20
NOMESCO Finland
More than three and less than five hours
1.9
15.9
250
1379
K04.09
ICD-10 Finland
Pulpit UNS
2.0
15.8
202
1029
N02AX02
ATC
tramadol; systemic, rectal
1.4
15.8
829
6232
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.5
15.7
603
4253
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
1.7
15.7
307
1818
SDC30
NOMESCO Finland
Strong parodontological fixation of 2-3 teeth
33.5
15.7
20
6
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.5
15.6
675
4883
N05AA02
ATC
levomepromazine; systemic
2.5
15.6
121
491
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.1
15.6
183
903
I10
ICD-10 Finland
Essential (primary) hypertension
1.6
15.5
431
2817
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.8
15.4
280
1619
196
Kela drug reimbursment
Paricalcitol and cinacalcet
9.5
15.4
31
33
T89
ICPC
Diabetes insulin dependent
2.0
15.3
203
1053
E66.01
ICD-10 Finland
Obesity due to excess calories
1.7
15.1
307
1841
K03.00
ICD-10 Finland
Approximal wear
2.1
15.0
176
868
ECA30
NOMESCO Finland
Excision of lesion of gingiva
5.6
14.9
43
78
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
10.1
14.9
29
29
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
3.6
14.8
67
190
R11
ICD-10 Finland
Nausea and vomiting
1.8
14.8
271
1572
ZST00
NOMESCO Finland
Procedure related to previous procedure classified in chapter T
31.8
14.8
19
6
H01
ICPC
Ear pain/earache
1.6
14.8
432
2857
SDC40
NOMESCO Finland
Strong parodontological fixation of 4-6 teeth
56.9
14.8
17
*
L03
ICPC
Low back symptom/complaint
1.4
14.8
750
5593
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
14.7
395
2558
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
13.2
14.7
25
19
SBB10
NOMESCO Finland
Teeth copy
1.8
14.6
246
1387
XCK10
NOMESCO Finland
Photography of fundus of eye
2.0
14.6
193
997
C02AC05
ATC
moxonidine; oral
5.0
14.5
46
93
K02.8
ICD-10 Finland
Other dental caries
2.9
14.4
86
299
T90
ICPC
Diabetes non-insulin dependent
1.9
14.4
210
1128
ECB00
NOMESCO Finland
Suture of gingiva
2.4
14.4
119
500
N06AX11
ATC
mirtazapine; oral
1.4
14.3
855
6558
SPAT1153
SPAT
Removal of sutures
1.5
14.3
631
4572
KAS20
NOMESCO Finland
Allogenic transplantation of kidney from living donor
22.3
14.2
20
9
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.3
14.2
134
600
C07AG02
ATC
carvedilol; oral
4.6
14.1
48
105
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
2.5
13.9
109
443
L12
ICPC
Hand/finger symptom/complaint
1.6
13.9
414
2752
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
2.2
13.9
145
679
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
4.3
13.9
51
121
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.9
13.8
205
1107
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
1.9
13.8
209
1138
T74.1
ICD-10 Finland
Physical abuse
2.3
13.8
127
564
B18.2
ICD-10 Finland
Chronic viral hepatitis C
2.8
13.8
89
323
K05.19
ICD-10 Finland
Gingivitis (chronic) ulcerative
2.8
13.7
89
325
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
13.6
13.7
23
17
SPA60
NOMESCO Finland
Fitting of intermediary dental prosthesis structures, 1 to 3 units
13.6
13.7
23
17
L02
ICPC
Back symptom/complaint
1.6
13.6
328
2064
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
13.6
1293
10671
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
10.1
13.4
26
26
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.3
13.4
129
582
K05.11
ICD-10 Finland
Gingivitis (chronic) hyperplastic
6.8
13.4
33
49
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
3.5
13.4
61
175
K05.1
ICD-10 Finland
Chronic gingivitis
1.7
13.3
283
1717
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
1.9
13.3
189
1004
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.1
13.3
149
723
WZC30
NOMESCO Finland
Teaching
1.8
13.3
240
1388
SDD01
NOMESCO Finland
Treatment of periodontal bite, restricted
11.5
13.3
24
21
K65.0
ICD-10 Finland
Acute peritonitis
7.3
13.2
31
43
VALMI
NOMESCO Finland
NA
1.3
13.2
980
7784
C10AA05
ATC
atorvastatin; oral
1.8
13.2
228
1300
L04AD01
ATC
ciclosporin; systemic
3.2
13.1
69
221
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
4.5
13.1
45
100
EBA30
NOMESCO Finland
Excision of root of tooth
2.4
13.1
108
455
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.8
13.0
245
1436
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.5
13.0
515
3649
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.1
13.0
71
234
ZXD10
NOMESCO Finland
Scheduled procedure
1.4
12.9
847
6587
AA1AD
NOMESCO Finland
CT of head and brain
1.6
12.9
349
2264
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.5
12.8
399
2678
SDA14
NOMESCO Finland
Treatment of complicated periodontal disease, extensive and very demanding
50.2
12.8
15
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.8
12.8
212
1189
Z00.0
ICD-10 Finland
General medical examination
1.5
12.8
536
3835
A05
ICPC
Feeling ill
1.7
12.8
285
1754
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
1.7
12.8
291
1801
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
8.5
12.7
27
32
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.5
12.7
396
2657
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.8
12.7
204
1136
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.8
12.7
220
1256
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
1.7
12.7
298
1863
N05AX12
ATC
aripiprazole; systemic
1.8
12.7
234
1362
N03AG01
ATC
valproic acid; systemic, rectal
1.8
12.6
225
1296
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
70.1
12.6
14
*
K05.28
ICD-10 Finland
Another acute periodontitis
5.5
12.5
36
66
D01
ICPC
Abdominal pain/cramps general
1.5
12.5
408
2768
C09AA05
ATC
ramipril; oral
2.0
12.5
170
890
N25.0
ICD-10 Finland
Renal osteodystrophy
24.4
12.4
17
7
H3603, E103
ICD-10 Finland
NA
2.9
12.4
74
258
T84.62
ICD-10 Finland
Osteitis associated with dental implants
20.1
12.4
18
9
EB1WA
NOMESCO Finland
NA
6.3
12.4
32
51
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
1.9
12.3
181
979
R51.80
ICD-10 Finland
Headache
1.4
12.2
567
4140
N05BA01
ATC
diazepam; systemic, rectal
1.7
12.2
285
1777
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.9
12.2
176
944
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.2
12.1
120
549
K05.08
ICD-10 Finland
Another acute gingivitis
2.3
12.0
110
488
K02.9
ICD-10 Finland
Dental caries, unspecified
3.1
12.0
65
213
R4110
NOMESCO Finland
Physiotherapy
1.4
12.0
539
3909
ZXA00
NOMESCO Finland
Right side
1.5
12.0
395
2689
N05BA04
ATC
oxazepam; oral
1.4
11.9
694
5280
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.9
11.9
174
935
ZXE10
NOMESCO Finland
More than one and less than three hours
1.4
11.9
789
6136
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
1.6
11.8
278
1739
TK810
NOMESCO Finland
Hemofiltration
7.0
11.8
28
40
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.0
11.8
150
766
5AB14
NOMESCO Finland
NA
14.7
11.8
19
13
SFA00
NOMESCO Finland
Small filling
1.5
11.8
365
2448
SXC03
NOMESCO Finland
Other oral or dental procedure
4.1
11.7
45
112
V03AE03
ATC
lanthanum carbonate; oral
8.9
11.7
24
27
ZXA05
NOMESCO Finland
Left side
1.5
11.6
378
2561
N06AB06
ATC
sertraline; oral
1.5
11.6
408
2811
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.7
11.6
226
1337
TPH07
NOMESCO Finland
Cathetrisation of artery
2.0
11.6
142
716
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
1.9
11.5
161
853
Z71.8
ICD-10 Finland
Other specified counselling
1.3
11.5
869
6895
F10.20
ICD-10 Finland
Alcohol dependence currently independent
2.9
11.5
71
252
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.6
11.4
327
2148
T84.60
ICD-10 Finland
Gingivitis associated with dental implants
13.6
11.4
19
14
SPAT1308
SPAT
Sexual health counselling
1.3
11.4
920
7370
C09CA01
ATC
losartan; oral
1.8
11.4
183
1019
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.5
11.4
405
2802
KA1AE
NOMESCO Finland
Kidney ultrasound examination
3.1
11.3
61
200
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.3
11.3
878
6994
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
1.7
11.3
225
1340
M05BA04
ATC
alendronic acid; oral
4.2
11.3
42
102
SPE01
NOMESCO Finland
Mucosa-supported partial denture
8.3
11.3
24
29
K06.10
ICD-10 Finland
Gingival fibromatosis
35.1
11.3
14
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.6
11.3
313
2044
N05CF01
ATC
zopiclone; oral
1.4
11.2
563
4169
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
1.5
11.2
372
2529
N06AX16
ATC
venlafaxine; oral
1.4
11.2
490
3532
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
2.1
11.1
123
594
S29
ICPC
Skin symptom/complaint other
1.5
11.1
402
2788
M54.4
ICD-10 Finland
Lumbago with sciatica
1.5
11.1
396
2740
N03AX16
ATC
pregabalin; oral
1.5
11.1
413
2886
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.5
11.1
446
3167
L28
ICPC
Limited function/disability (L)
1.8
11.0
195
1123
WX892
NOMESCO Finland
Monitored bed care
2.0
11.0
144
745
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
1.5
11.0
393
2721
J01FF01
ATC
clindamycin; systemic
1.4
11.0
698
5386
SPE02
NOMESCO Finland
Metal-framed partial denture
13.9
11.0
18
13
K05.21
ICD-10 Finland
Periodontal abscess with fistula
6.6
10.9
27
41
K04.00
ICD-10 Finland
Hyperemia of pulp
1.8
10.9
190
1085
SPA47
NOMESCO Finland
Precision impression for denture
6.9
10.8
26
38
PARO
NOMESCO Finland
NA
11.9
10.8
19
16
WX872
NOMESCO Finland
Intensive care
2.6
10.8
77
301
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.5
10.8
442
3148
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
10.7
1021
8365
N19
ICD-10 Finland
Unspecified kidney failure
4.7
10.7
35
75
A10AE05
ATC
insulin detemir; parenteral
1.8
10.7
166
916
WW200
NOMESCO Finland
Immunization
2.3
10.7
94
408
K04.62
ICD-10 Finland
Periradicular abscess with fistula to mouth
2.7
10.6
71
267
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.8
10.6
178
1005
SBA10
NOMESCO Finland
Measurement of excretion of saliva
4.6
10.6
35
76
XPX08
NOMESCO Finland
Intraoperative flow measurement
14.2
10.5
17
12
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.6
10.5
46
130
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.2
10.4
101
461
A10BA02
ATC
metformin; oral
1.6
10.4
293
1919
C08CA13
ATC
lercanidipine; oral
2.5
10.4
78
315
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.4
10.3
436
3124
EAB10
NOMESCO Finland
Excision and repair of frenum of lip
10.6
10.3
19
18
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
10.3
222
1356
T82
ICPC
Obesity
2.0
10.2
130
667
M79.1
ICD-10 Finland
Myalgia
1.5
10.2
395
2781
P06
ICPC
Sleep disturbance
1.5
10.2
326
2202
P74
ICPC
Anxiety disorder/anxiety state
1.7
10.1
211
1277
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
10.1
1073
8909
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
1.4
10.1
493
3634
A46
ICD-10 Finland
Erysipelas
1.7
10.1
188
1102
R07.4
ICD-10 Finland
Chest pain, unspecified
1.5
10.1
404
2863
CKC12
NOMESCO Finland
Photocoagulation of retina
2.2
10.0
98
448
Z3226
NOMESCO Finland
Physiotherapist
1.5
10.0
397
2806
N03AX09
ATC
lamotrigine; oral
1.7
10.0
218
1338
Z86.4
ICD-10 Finland
Personal history of psychoactive substance abuse
3.5
10.0
44
125
Z72.2
ICD-10 Finland
Drug use
3.2
10.0
50
157
XCH00
NOMESCO Finland
Eye pressure measurement
2.9
9.9
58
201
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
1.9
9.9
140
746
P29
ICPC
Psychological sympt/compl other
1.5
9.9
294
1953
SPAT1307
SPAT
Psychosocial counselling and guidance
1.5
9.9
380
2672
XF400
NOMESCO Finland
ECG with 12 standard connections
1.6
9.9
233
1460
TJW99
NOMESCO Finland
Other minor procedure in gastrointestinal endoscopy
16.7
9.9
15
9
TK824
NOMESCO Finland
Replacement of peritoneal dialysis catheter extension tube
16.7
9.9
15
9
ECA35
NOMESCO Finland
Complicated excision of lesion of gingiva
12.2
9.8
17
14
R21
ICPC
Throat symptom/complaint
1.3
9.8
1034
8569
SCA03
NOMESCO Finland
Preventive oral health care, extensive
1.7
9.8
206
1249
P15
ICPC
Chronic alcohol abuse
2.2
9.8
94
428
C07AB07
ATC
bisoprolol; oral
1.4
9.8
481
3546
A01
ICPC
Pain general/multiple sites
1.8
9.8
173
998
H43.1
ICD-10 Finland
Vitreous haemorrhage
3.1
9.8
51
165
SPA02
NOMESCO Finland
Preparation for dental prosthetics
4.2
9.7
35
83
BBA40
NOMESCO Finland
Subtotal parathyroidectomy
9.5
9.7
19
20
R07
ICPC
Sneezing/nasal congestion
1.5
9.7
314
2126
N05CD07
ATC
temazepam; oral
2.2
9.7
96
443
K07.24
ICD-10 Finland
Open bite
2.6
9.7
66
252
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.8
9.7
150
828
M01AE01
ATC
ibuprofen; systemic, rectal
1.4
9.7
3312
31654
ZXA10
NOMESCO Finland
Bilateral
1.5
9.7
335
2305
Z96.5
ICD-10 Finland
Presence of tooth-root and mandibular implants
13.4
9.7
16
12
N05AX08
ATC
risperidone; systemic
1.6
9.6
226
1414
Z2221
NOMESCO Finland
Medical doctor
1.3
9.6
833
6719
Z73.8
ICD-10 Finland
Other problems related to life-management difficulty
3.3
9.6
46
140
WYA50
NOMESCO Finland
Student oral health check consistent with decree to assess need for oral health guidance and services
0.5
9.6
75
1467
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
2.0
9.5
112
558
H05BX01
ATC
cinacalcet; oral
8.4
9.5
20
24
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
9.5
994
8222
K05.0
ICD-10 Finland
Acute gingivitis
2.1
9.5
102
490
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.9
9.5
132
700
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
2.6
9.4
66
257
K05.2
ICD-10 Finland
Acute periodontitis
4.9
9.4
29
59
N02AA05
ATC
oxycodone; systemic
1.9
9.4
136
734
ZYC01
NOMESCO Finland
Remote contact by phone
1.8
9.4
149
830
L01
ICPC
Neck symptom/complaint
1.4
9.4
395
2827
P19
ICPC
Drug abuse
2.4
9.3
75
315
B03XA01
ATC
erythropoietin; parenteral
8.0
9.3
20
25
I50.9
ICD-10 Finland
Heart failure, unspecified
3.5
9.3
41
117
C08CA02
ATC
felodipine; oral
3.3
9.3
44
133
N03AX12
ATC
gabapentin; oral
1.5
9.2
276
1835
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
13.7
9.2
15
11
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
13.7
9.2
15
11
M25.5
ICD-10 Finland
Pain in joint
1.3
9.1
730
5821
L04AX01
ATC
azathioprine; systemic
1.8
9.1
145
810
P03
ICPC
Feeling depressed
1.4
9.1
475
3539
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
2.0
9.0
116
597
WX110
SPAT
NA
1.8
9.0
161
933
ECA10
NOMESCO Finland
Incision of gingiva
3.1
9.0
47
153
S22.3
ICD-10 Finland
Fracture of rib
2.0
9.0
108
545
TKC20
NOMESCO Finland
Catheterisation of bladder
2.1
9.0
98
473
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.1
9.0
101
496
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
1.9
8.9
128
687
R06.0
ICD-10 Finland
Dyspnoea
1.4
8.9
444
3279
K12.2
ICD-10 Finland
Cellulitis and abscess of mouth
3.2
8.9
45
143
G47.3
ICD-10 Finland
Sleep apnoea
1.5
8.9
341
2395
P17
ICPC
Tobacco abuse
2.7
8.9
57
211
ULA02
NOMESCO Finland
Kolposcopy
1.4
8.9
368
2624
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
2.6
8.8
60
229
SXC05
NOMESCO Finland
Other oral or dental procedure
1.7
8.8
190
1165
EBB10
NOMESCO Finland
Insertion of dental implant
3.2
8.8
44
139
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
1.8
8.8
144
812
WX402
NOMESCO Finland
General anaesthesia
1.4
8.7
431
3176
J01DB01
ATC
cefalexin; oral
1.3
8.7
2809
26329
SPE90
NOMESCO Finland
Other fitting and preparation of partial tooth prosthesis
5.9
8.7
23
39
L04AA05
ATC
[U] tacrolimus; systemic
14.0
8.7
14
10
F29
ICD-10 Finland
Unspecified nonorganic psychosis
1.6
8.6
206
1296
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
1.6
8.6
248
1637
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
3.0
8.6
49
167
H02AB04
ATC
methylprednisolone; systemic
1.5
8.6
255
1697
Y04.9
ICD-10 Finland
Assault by bodily force by unknown person
2.6
8.6
60
235
WX704
NOMESCO Finland
Intubation
1.7
8.5
165
979
SPAT1281
SPAT
Other administrative function
1.6
8.5
233
1520
ZXD05
NOMESCO Finland
Urgent procedure
1.3
8.5
1010
8471
SPAT1097
SPAT
Recording of ECG
1.7
8.5
185
1136
A10AA01
ATC
NA
1.8
8.5
132
731
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
2.3
8.5
72
312
JAETT
NOMESCO Finland
NA
5.6
8.4
23
41
SPAT1360
SPAT
Extensive global examination
1.7
8.3
153
894
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.6
8.3
214
1374
K08.80
ICD-10 Finland
Toothache NOS
1.5
8.3
275
1873
RTGBW
NOMESCO Finland
NA
9.4
8.3
16
17
R60.9
ICD-10 Finland
Oedema, unspecified
2.3
8.3
71
310
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.7
8.3
176
1073
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.3
8.3
73
322
H13
ICPC
Plugged feeling ear
1.5
8.2
282
1935
Z25
ICPC
Assault/harmful event problem
2.8
8.2
50
181
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.7
8.2
53
198
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
1.9
8.2
110
580
G63.2*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic polyneuropathy
6.5
8.2
20
31
3AC01
NOMESCO Finland
NA
3.5
8.1
36
104
Z72.1
ICD-10 Finland
Alcohol use
3.1
8.1
43
142
A99
ICPC
Disease/condition unspecnature/site
1.7
8.1
165
995
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
1.7
8.1
154
907
L84
ICPC
Back syndrome without radiat pain
1.9
8.1
117
630
SPAT1227
SPAT
Substance abuse rehabilitation
3.1
8.1
42
137
H05BX02
ATC
paricalcitol; systemic
33.4
8.1
10
*
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
2.7
8.0
53
201
K07.13
ICD-10 Finland
Retrognaty, mandibular
2.5
8.0
59
236
XF612
NOMESCO Finland
Measurement of central venous pressure
22.1
8.0
11
5
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.0
8.0
93
461
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
5.5
8.0
22
40
R50.9
ICD-10 Finland
Fever, unspecified
1.4
8.0
383
2809
ZY010
NOMESCO Finland
Hospital outpatient
1.6
7.9
222
1453
D06
ICPC
Abdominal pain localized other
1.5
7.9
262
1782
SPAT1211
SPAT
Application of soft bandage
1.6
7.9
197
1253
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
2.1
7.9
83
396
F10.24
ICD-10 Finland
Alcohol depence active use
2.7
7.9
51
191
N03AF01
ATC
carbamazepine; oral, rectal
2.2
7.9
78
362
K00.09
ICD-10 Finland
Lack of teeth due to lack of dental development UNS
4.9
7.9
24
49
T86.1
ICD-10 Finland
Kidney transplant failure and rejection
13.0
7.9
13
10
N05AF03
ATC
chlorprothixene; systemic
2.1
7.9
83
397
F43.1
ICD-10 Finland
Post-traumatic stress disorder
1.8
7.8
136
782
F10.25
ICD-10 Finland
Alcohol dependence continuous use
2.7
7.8
50
184
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
2.9
7.8
46
162
SPAT1058
SPAT
PEF monitoring instruction
1.7
7.8
165
1005
TQW80
NOMESCO Finland
Local dermatologic skincare
2.5
7.8
58
235
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
2.1
7.8
87
425
F32
ICD-10 Finland
Depressive episode
1.5
7.8
222
1463
RS220
NOMESCO Finland
NA
2.7
7.8
51
193
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.5
7.8
228
1512
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
2.7
7.8
50
186
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
9.4
7.8
15
16
E10
ICD-10 Finland
Type 1 diabetes mellitus
2.0
7.8
100
517
SFC00
NOMESCO Finland
Pillar of fillings material
2.6
7.8
52
200
S22
ICPC
Nail symptom/complaint
1.9
7.8
116
633
A10AA02
ATC
NA
1.8
7.7
128
726
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
1.8
7.7
126
711
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
1.7
7.7
157
946
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
4.2
7.7
27
64
TLOPK
NOMESCO Finland
NA
5.3
7.7
22
42
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.7
7.7
157
949
F43.20
ICD-10 Finland
Adaptation disorder with short-term depression
2.4
7.7
63
268
K07.60
ICD-10 Finland
Snapping jaw
1.6
7.7
191
1216
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.5
7.6
234
1569
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
3.7
7.6
31
84
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
1.5
7.6
273
1893
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
2.5
7.6
56
224
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
2.7
7.6
49
183
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.5
7.6
226
1506
A29
ICPC
General symptom/complaint other
1.5
7.6
226
1506
H36.00
ICD-10 Finland
Diabetic background retinopathy
2.5
7.6
54
215
SDPHK
NOMESCO Finland
NA
25.0
7.6
10
*
H29
ICPC
Ear symptom/complaint other
1.6
7.6
190
1212
RD211
NOMESCO Finland
NA
2.0
7.6
88
440
C02CA01
ATC
prazosin; oral
10.0
7.5
14
14
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
1.7
7.5
149
894
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
5.4
7.5
21
39
R02
ICPC
Shortness of breath/dyspnoea
1.5
7.5
254
1740
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
3.4
7.5
34
101
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.1
7.5
81
394
D09
ICPC
Nausea
1.6
7.4
192
1233
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.6
7.4
50
193
B05D
ATC
PERITONEAL DIALYTICS
80.2
7.4
8
*
K07.25
ICD-10 Finland
Anomalies of dental arch relationship
2.5
7.4
55
222
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
1.7
7.4
146
875
SDD02
NOMESCO Finland
Treatment of periodontal bite
13.4
7.4
12
9
R33
ICD-10 Finland
Retention of urine
2.3
7.4
62
269
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
3.0
7.4
39
130
E66.8
ICD-10 Finland
Other obesity
1.7
7.3
152
921
K05
ICD-10 Finland
Gingivitis and periodontal diseases
2.8
7.3
43
152
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
2.3
7.3
64
282
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.7
7.3
140
830
SPAT1192
SPAT
Gynaecological examination
1.3
7.3
602
4804
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
2.2
7.3
70
323
F40.2
ICD-10 Finland
Specific (isolated) phobias
2.6
7.3
48
183
WW400
NOMESCO Finland
Plasmaferesis
9.4
7.3
14
15
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
3.9
7.2
28
73
N05AB03
ATC
perphenazine; systemic, rectal
2.0
7.2
92
476
SCD02
NOMESCO Finland
Removal of tooth plaque or tartar
3.7
7.2
29
78
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.5
7.2
241
1647
SPAT1265
SPAT
Breathalyser
2.7
7.2
47
177
K85
ICPC
Elevated blood pressure
1.8
7.2
127
736
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
2.3
7.2
61
266
X59
ICD-10 Finland
Exposure to unspecified factor
1.3
7.2
527
4139
N05BA06
ATC
lorazepam; systemic, sublingual
1.9
7.2
92
478
L08
ICPC
Shoulder symptom/complaint
1.4
7.2
301
2151
K02.2
ICD-10 Finland
Caries of cementum
2.3
7.2
60
258
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.5
7.1
248
1709
N06AB03
ATC
fluoxetine; oral
1.4
7.1
289
2057
A02BC01
ATC
omeprazole; systemic
1.3
7.1
535
4218
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.5
7.1
249
1721
ECB40
NOMESCO Finland
Surgical treatment of fracture of alveolus
4.0
7.1
26
65
D02
ICPC
Abdominal pain epigastric
1.6
7.1
158
982
EBB15
NOMESCO Finland
Insertion of dental implant abutment
3.8
7.0
28
75
A10AD01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
2.0
7.0
86
438
ZXE00
NOMESCO Finland
One hour or less
1.2
7.0
1106
9536
F41.09
ICD-10 Finland
UNS Panic Syndrome
1.6
7.0
159
992
H3601, E103
ICD-10 Finland
NA
2.3
7.0
60
264
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.1
7.0
72
343
L04AA01
ATC
[U] ciclosporin; systemic
3.1
6.9
35
113
F41.00
ICD-10 Finland
Moderate panic disorder
1.9
6.9
92
485
F61.0
ICD-10 Finland
Mixed personality disorders
2.0
6.9
81
407
A10AE06
ATC
insulin degludec; parenteral
1.8
6.9
111
623
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.0
6.9
83
421
K02
ICD-10 Finland
Dental caries
1.5
6.9
209
1398
P72
ICPC
Schizophrenia
2.1
6.9
72
346
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.3
6.9
58
251
R60.0
ICD-10 Finland
Localized oedema
1.7
6.9
136
816
P01
ICPC
Feeling anxious/nervous/tense
1.3
6.9
588
4715
SPAT1234
SPAT
Support of social functional capacity
1.9
6.9
89
465
N05AH02
ATC
clozapine; systemic
1.9
6.8
99
537
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.4
6.8
273
1935
H3602, E103
ICD-10 Finland
NA
3.7
6.8
28
77
F39
ICD-10 Finland
Unspecified mood [affective] disorder
1.9
6.8
95
508
NHQ40
NOMESCO Finland
Amputation of toe
6.7
6.8
16
24
R5430
NOMESCO Finland
Interpreter's services
5.0
6.8
20
40
O24.4
ICD-10 Finland
Diabetes mellitus arising in pregnancy
1.3
6.8
454
3515
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.6
6.8
153
950
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
3.5
6.8
29
83
WX003
NOMESCO Finland
Sedation or analgesia orally, rectally or intramuscularly without general anesthesia
5.3
6.8
19
36
SAATP
NOMESCO Finland
NA
40.1
6.8
8
*
K00.00
ICD-10 Finland
Hypodontia
2.5
6.7
51
209
H04AA01
ATC
glucagon; nasal, parenteral
1.6
6.7
156
977
F90.0
ICD-10 Finland
Disturbance of activity and attention
1.6
6.7
186
1219
K05.09
ICD-10 Finland
Acute gingivitis, UNS
2.4
6.7
51
211
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.6
6.7
157
986
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.1
6.7
34
111
S08
ICPC
Skin colour change
2.0
6.7
81
412
S11
ICPC
Skin infection post-traumatic
3.0
6.6
35
117
R4190
NOMESCO Finland
Nutritional therapy
1.9
6.6
87
456
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
1.6
6.6
172
1110
WW500
NOMESCO Finland
Blood transfusion
2.0
6.6
81
416
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
5.5
6.6
18
33
SPAT1210
SPAT
Application of cast or individual aid
1.8
6.6
99
547
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.3
6.6
579
4663
ZY000
NOMESCO Finland
Hospital inpatient
2.2
6.6
64
298
Z06
ICPC
Unemployment problem
2.9
6.5
38
134
ECA20
NOMESCO Finland
Biopsy of gingiva
4.3
6.5
22
51
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
2.1
6.5
69
334
Z29
ICPC
Social problem NOS
2.0
6.5
76
384
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
1.3
6.5
429
3320
RTGHF
NOMESCO Finland
NA
6.2
6.5
16
26
Z46.3
ICD-10 Finland
Fitting and adjustment of dental prosthetic device
6.2
6.5
16
26
SCB02
NOMESCO Finland
Training for mouth care at home
5.3
6.4
18
34
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.7
6.4
135
824
P18
ICPC
Medication abuse
2.9
6.4
35
120
SPAT1229
SPAT
Assessment of need for aid
2.0
6.4
73
364
S04
ICPC
Lump/swelling localized
1.4
6.4
266
1903
SPC10
NOMESCO Finland
Attachment of standard crone of tooth
3.0
6.4
33
109
N05BA12
ATC
alprazolam; oral
1.5
6.4
215
1473
XCK00
NOMESCO Finland
Perimetry
1.9
6.4
83
434
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
1.8
6.4
108
617
J01AA04
ATC
lymecycline; systemic
0.7
6.4
298
3940
F60.9
ICD-10 Finland
Personality disorder, unspecified
2.0
6.3
74
370
N06AB05
ATC
paroxetine; oral
1.5
6.3
180
1188
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
1.8
6.3
93
510
N06AB10
ATC
escitalopram; oral
1.2
6.3
782
6559
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.5
6.3
205
1392
C10AA07
ATC
rosuvastatin; oral
1.6
6.3
147
925
SPAT1272
SPAT
Drug screening
2.8
6.3
37
132
SPA05
NOMESCO Finland
Guiding rail
11.0
6.3
11
10
SPAT1285
SPAT
Provision of consultation response
1.7
6.3
111
644
Z36.8
ICD-10 Finland
Other antenatal screening
1.7
6.3
115
677
E10.01
ICD-10 Finland
Insulin-dependent diabetes diabetic coma with hyperglycemia
4.0
6.3
23
58
LDC03
NOMESCO Finland
Conisation of cervix uteri using diathermy or laser
1.6
6.3
161
1039
EBA12
NOMESCO Finland
Complicated surgical removal of tooth
1.6
6.3
170
1110
SPAT1363
SPAT
Health check-up performed during first study year in students of upper secondary schools, vocational schools etc.
1.4
6.3
357
2699
RJ414
NOMESCO Finland
NA
18.0
6.3
9
5
Z01.8
ICD-10 Finland
Other specified special examinations
1.3
6.3
469
3693
A10BJ06
ATC
semaglutide; parenteral
2.5
6.3
43
170
K04.6
ICD-10 Finland
Periapical abscess with sinus
2.9
6.2
34
117
G40.9
ICD-10 Finland
Epilepsy, unspecified
1.9
6.2
86
460
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
1.6
6.2
154
982
VALPA
NOMESCO Finland
NA
26.7
6.2
8
*
N03AE01
ATC
clonazepam; systemic
1.7
6.2
121
723
M72.2
ICD-10 Finland
Plantar fascial fibromatosis
1.6
6.2
149
941
CKD92
NOMESCO Finland
Combined vitrectomy and retinal procedure
4.8
6.2
19
40
BEF00
NOMESCO Finland
Continuous subcutaneous glucose monitoring
2.3
6.2
51
220
K07.23
ICD-10 Finland
Deep bite
2.0
6.2
71
355
SPAT1395
SPAT
Health check-up of persons outside student and working life
2.1
6.2
62
294
TUPKY
NOMESCO Finland
NA
2.5
6.2
44
175
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.3
6.2
464
3656
EB1BA
NOMESCO Finland
Extensive intraoral X-ray examination
5.7
6.1
16
28
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
2.4
6.1
48
203
321
Kela drug reimbursment
Paricalcitol and cinacalcet
7.7
6.1
13
17
J01MA12
ATC
levofloxacin; systemic
1.4
6.1
278
2020
M77.9
ICD-10 Finland
Enthesopathy, unspecified
1.9
6.1
79
415
K05.29
ICD-10 Finland
Acute periodontitis UNS
4.7
6.1
19
41
B01AB05
ATC
enoxaparin; parenteral
1.3
6.1
457
3599
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
3.0
6.1
32
108
M54
ICD-10 Finland
Dorsalgia
1.4
6.1
346
2614
R53
ICD-10 Finland
Malaise and fatigue
1.3
6.0
543
4381
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.4
6.0
296
2180
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.5
6.0
215
1493
P16
ICPC
Acute alcohol abuse
2.2
6.0
55
249

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1872
13370
1.68
59.77
5.4
4.6
umol/l
9.4
10.1
2.91
1764
12486
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
64
65
9.97
56.04
5.9
5.0
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2747
21880
1.64
55.31
7.9
6.0
u/l
71.2
69.0
3.56
2606
20633
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1304
8617
1.72
54.53
3.4
2.5
u/l
53.9
55.9
0.65
1218
7996
(3042733) HLA Ab [Presence] in Serum
75
104
7.32
51.23
6.0
4.4
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
508
2518
2.15
51.19
14.1
6.3
mmol/l
1.1
1.1
3.56
483
2388
(3013826) Glucose [Moles/volume] in Serum or Plasma
2157
16464
1.59
49.52
5.5
4.0
mmol/l
6.5
6.2
7.90
1914
14176
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1506
10689
1.61
46.09
10.6
5.4
mmol/l
1.2
1.2
0.52
1284
8981
(3032080) INR in Blood by Coagulation assay
1148
7620
1.68
45.84
4.6
4.2
inr
1.0
1.1
0.38
415
2862
(3020682) Albumin/Creatinine [Ratio] in Urine
751
4499
1.80
42.97
6.5
4.8
mg/mmol
22.0
15.2
1.77
577
3297
(3012516) Albumin [Mass/volume] in Urine
730
4337
1.81
42.94
5.5
3.9
mg/l
386.5
398.6
0.03
547
3111
(3009508) Creatinine [Moles/volume] in Urine
1092
7273
1.66
42.55
5.4
3.6
mmol/l
8.6
9.0
1.42
970
6444
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1351
9490
1.60
42.42
9.6
5.0
mmol/l
1.2
1.2
0.44
1243
8671
(40768446) Kidney Pathology biopsy report
77
138
5.66
41.04
2.5
1.5
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
3671
32436
1.68
40.32
12.6
7.5
mmol/l
139.3
139.4
4.28
3575
31316
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
277
1178
2.44
39.91
9.8
4.0
ng/l
121.7
79.3
4.37
258
1088
(3023103) Potassium [Moles/volume] in Serum or Plasma
3674
32558
1.66
38.85
12.9
7.6
mmol/l
3.9
3.9
9.23
3566
31325
(3024561) Albumin [Mass/volume] in Serum or Plasma
1414
10230
1.55
38.24
6.2
4.6
g/l
37.2
37.9
5.00
1317
9506
(3020779) Urea [Moles/volume] in Serum or Plasma
333
1596
2.17
36.18
17.2
8.0
mmol/l
9.1
6.3
11.00
327
1540
(3002032) Base excess in Venous blood by calculation
331
1634
2.11
33.28
9.0
4.0
mmol/l
1.1
1.6
1.05
273
1310
(3021447) Carbon dioxide [Partial pressure] in Venous blood
332
1646
2.10
33.00
8.4
4.0
kpa
5.8
5.9
0.60
326
1581
(3018418) pH of Serum or Plasma
927
6289
1.59
32.30
8.1
3.5
ph
7.4
7.4
0.24
200
1246
(3023368) Bacteria identified in Blood by Culture
820
5460
1.61
30.72
4.5
3.7
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
30
24
12.58
30.62
8.2
6.2
mmol/l
6.2
6.0
0.07
30
24
(3042936) Bacteria identified in Isolate by Culture
601
3725
1.71
29.70
2.1
1.9
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
50
81
6.23
29.58
4.2
2.9
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
3498
31330
1.50
28.23
10.5
6.7
ml/min/173m2
102.2
102.9
1.05
2777
24548
(3013707) Erythrocyte sedimentation rate by Westergren method
2714
23203
1.42
27.94
4.1
3.3
mm/h
9.0
7.2
12.99
2523
21827
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
171
698
2.51
26.90
8.6
4.8
iu/ml
306.6
996.8
1.41
38
62
(3000991) Gas panel - Venous blood
302
1558
2.00
26.86
12.5
8.7
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
3042
26641
1.43
26.65
4.7
3.3
mmol/mol
38.5
36.4
18.36
2900
25447
(3020564) Creatinine [Moles/volume] in Serum or Plasma
4022
37310
1.66
26.29
12.7
8.0
umol/l
73.8
70.3
5.87
4022
37289
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1480
11462
1.43
26.24
3.6
3.0
u/l
29.3
29.7
0.14
1407
10905
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
137
508
2.75
26.15
4.8
2.8
u/ml
126.0
1897.7
—
5
20
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
873
6106
1.53
25.91
2.3
2.0
u/l
264.7
255.2
0.06
829
5803
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
3592
32521
1.49
25.84
4.8
4.4
mu/l
1.8
1.9
0.26
3386
31040
(3000850) Epithelial cells [#/volume] in Urine
801
5521
1.55
25.37
3.5
2.2
e6/l
8.3
8.2
0.03
718
4757
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
3184
28221
1.42
25.26
4.0
3.9
pmol/l
14.4
14.4
0.11
2948
26422
(3024932) HLA-DR beta [Type]
53
106
5.05
25.12
1.0
1.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
1361
10454
1.43
24.98
7.8
6.1
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
2027
16693
1.39
24.72
8.0
6.0
e9/l
0.6
0.5
9.64
1822
14870
(3002582) Erythrocytes [#/volume] in Urine
1094
8082
1.47
24.69
4.0
2.6
e6/l
130.6
70.5
0.25
867
5941
(3012095) Magnesium [Moles/volume] in Serum or Plasma
532
3347
1.67
24.61
5.0
3.4
mmol/l
0.8
0.8
5.54
500
3138
(3017143) Hepatitis C virus Ab [Presence] in Serum
1205
9103
1.44
24.05
2.1
1.7
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
2254
18956
1.37
23.82
11.2
8.4
e9/l
4.3
4.0
9.26
2027
16743
(3006315) Basophils [#/volume] in Blood
2025
16742
1.38
23.79
8.0
6.0
e9/l
0.0
0.0
6.52
1823
14882
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
393
2297
1.78
23.70
4.1
4.0
u/l
226.5
221.4
0.33
376
2186
(3024471) HLA-A [Type]
52
108
4.86
23.61
1.0
1.0
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
54
116
4.70
23.56
23.4
26.9
ug/l
111.0
109.6
0.05
42
96
(3026782) Osmolality of Urine
752
5190
1.54
23.51
3.5
2.3
mosm/kgh2o
541.4
557.8
1.04
663
4377
(3013115) Eosinophils [#/volume] in Blood
2081
17368
1.36
22.63
8.6
6.3
e9/l
0.2
0.2
2.61
1922
15668
(3031040) Bacteria [#/volume] in Urine by Automated count
2659
23068
1.37
22.52
4.6
3.6
e6/l
1954.1
786.8
0.56
43
255
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
497
3153
1.65
22.15
4.6
2.3
%
23.8
25.1
1.19
426
2731
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
210
1019
2.11
22.05
11.8
4.0
mmol/l
23.5
24.1
1.67
199
913
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1581
12675
1.38
21.93
2.7
2.2
nmol/l
68.1
69.9
2.03
1479
12031
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1176
8973
1.42
21.84
1.7
1.6
pmol/l
97.5
99.2
0.67
643
5123
(3006504) Eosinophils/100 leukocytes in Blood
1914
15839
1.36
21.65
7.9
5.9
%
2.7
2.7
0.06
1786
14925
(3030467) Casts [#/volume] in Urine by Automated count
983
7283
1.45
21.40
3.9
2.5
e6/l
0.2
0.2
0.14
766
5252
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1009
7526
1.44
21.15
2.6
2.1
ng/l
294.9
24.9
0.50
408
2347
(36304419) Bacteria [Presence] in Urine
1001
7461
1.44
21.05
3.8
2.5
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
1921
15963
1.35
20.91
8.1
6.1
%
7.9
7.9
0.70
1809
15153
(3022096) Basophils/100 leukocytes in Blood
1850
15289
1.35
20.86
8.1
6.0
%
0.6
0.7
0.23
1729
14412
(3019198) Lymphocytes [#/volume] in Blood
2089
17590
1.35
20.79
7.9
5.9
e9/l
2.1
2.0
3.89
1922
15959
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
532
3492
1.59
20.57
2.0
1.7
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
484
3106
1.62
20.54
2.7
2.7
umol/l
4.9
6.1
2.54
394
2587
(3026008) Bacteria identified in Urine by Culture
1051
7947
1.42
20.31
2.7
2.1
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
216
1094
2.02
20.22
4.6
2.6
kpa
5.1
5.1
0.15
199
1026
(3004119) Hemoglobin [Mass/volume] in Venous blood
200
990
2.07
19.93
4.7
3.5
g/l
131.8
136.7
2.03
195
967
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
173
810
2.18
19.92
2.9
2.2
g/l
1.3
1.2
1.34
156
713
(3022948) Iron [Moles/volume] in Serum or Plasma
582
3929
1.55
19.88
4.1
2.2
umol/l
14.1
15.3
3.10
548
3675
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
299
1698
1.81
19.81
1.8
1.7
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
2773
24460
1.34
19.66
5.0
3.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
1815
15060
1.34
19.52
10.2
7.6
e9/l
0.0
0.0
0.67
1550
12407
(3029937) Albumin [Presence] in Urine by Test strip
1186
9209
1.39
19.51
3.9
3.1
estimate
0.0
0.0
2.76
476
3649
(3004789) Transferrin [Mass/volume] in Serum or Plasma
531
3526
1.57
19.49
4.3
2.2
g/l
2.4
2.5
4.31
493
3268
(3027945) Reticulocytes/100 erythrocytes in Blood
312
1810
1.78
19.25
4.2
3.1
%
1.8
1.6
1.80
286
1632
(3009343) pH of Capillary blood
212
1086
2.00
19.23
4.5
2.6
ph
7.4
7.4
0.33
34
152
(3023520) Reticulocytes [#/volume] in Blood
222
1156
1.97
19.22
3.5
2.7
e9/l
78.3
72.3
1.13
156
804
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
207
1053
2.01
19.15
4.3
2.6
mmol/l
1.1
0.9
0.33
142
700
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
3325
30216
1.37
18.98
3.3
2.6
mmol/l
5.8
5.5
16.38
3107
28477
(3021960) Folate [Moles/volume] in Serum or Plasma
681
4800
1.49
18.93
1.6
1.4
nmol/l
18.4
20.1
2.35
607
4375
(3018010) Neutrophils/100 leukocytes in Blood
1973
16650
1.33
18.58
7.5
5.6
%
56.8
56.0
2.68
1849
15822
(3002030) Lymphocytes/100 leukocytes in Blood
1995
16882
1.32
18.35
7.8
5.8
%
29.6
30.4
3.20
1875
16006
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
3931
36838
1.49
18.34
13.1
8.6
mg/l
18.7
19.3
0.54
3153
27546
(3026493) Urate [Moles/volume] in Serum or Plasma
800
5859
1.44
18.20
2.9
2.1
umol/l
1070.6
2150.0
1.09
728
5357
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
4036
38062
1.52
17.90
10.0
7.0
u/l
28.6
27.8
0.92
3920
37005
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
309
1831
1.74
17.70
2.6
2.6
g/l
0.2
0.2
0.64
293
1705
(3017181) Myelocytes/100 leukocytes in Blood
367
2282
1.66
17.59
5.0
4.4
%
0.6
0.8
0.93
99
470
(3018677) aPTT in Platelet poor plasma by Coagulation assay
496
3320
1.55
17.50
3.0
2.4
s
29.4
29.2
0.61
479
3194
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
57
160
3.59
17.49
1.3
1.3
u/l
66.5
57.4
0.66
49
106
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
865
6468
1.42
17.47
1.7
1.5
mmol/l
1.6
1.4
2.99
743
5804
(3000494) Fungus identified in Specimen by Culture
497
3330
1.55
17.45
1.6
1.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
356
2204
1.67
17.34
5.1
4.5
%
0.1
0.1
1.00
96
446
(3022313) Gas panel - Capillary blood
151
709
2.17
17.30
4.8
2.7
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
296
1748
1.74
17.16
7.8
8.2
mmol/l
-0.0
0.4
0.63
207
1272
(3028707) Methadone [Presence] in Urine by Screen method
342
2118
1.66
16.63
3.8
3.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
2047
17553
1.30
16.44
3.7
2.9
estimate
0.0
0.0
1.30
469
3644
(3035350) Ketones [Presence] in Urine by Test strip
2034
17435
1.30
16.35
3.7
2.9
estimate
0.0
0.0
1.34
472
3606
(3019150) Specific gravity of Urine by Refractometry
998
7722
1.37
16.32
3.4
3.0
kg/l
1.0
1.0
1.24
131
1161
(3007853) Bacteria identified in Skin by Aerobe culture
548
3802
1.50
16.32
1.8
1.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
511
3502
1.52
16.13
5.3
3.4
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
290
1736
1.72
16.01
7.8
8.3
kpa
13.6
14.3
1.06
272
1647
(3024928) Oxygen saturation in Venous blood
101
413
2.48
15.96
5.6
3.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
341
2137
1.64
15.83
4.9
4.1
%
0.3
0.5
1.37
73
355
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
182
948
1.96
15.78
1.8
2.1
ug/l
8.2
6.0
0.52
157
824
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
289
1736
1.71
15.76
7.9
8.3
kpa
4.9
5.0
0.35
273
1645
(3019309) Folate [Moles/volume] in Red Blood Cells
470
3185
1.53
15.62
1.6
1.6
nmol/l
1071.5
1167.7
1.52
382
2495
(3025159) Blasts/100 leukocytes in Blood
340
2139
1.64
15.54
5.1
4.5
%
0.0
0.0
2.77
80
391
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
405
2669
1.57
15.25
2.8
2.6
ng/l
1296.2
505.3
1.57
297
1925
(3020191) Ethanol [Moles/volume] in Serum or Plasma
92
368
2.53
15.24
1.5
1.6
promille
1.4
1.4
0.17
70
283
(40761511) CBC panel - Blood by Automated count
4131
39364
1.52
15.14
11.7
8.0
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
182
963
1.93
15.08
2.5
1.9
titre
4.4
10.9
—
5
23
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1951
16755
1.29
15.00
4.2
4.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
2021
17452
1.28
14.81
5.0
4.0
estimate
0.0
0.0
1.08
488
3759
(3018095) Leukocytes [#/volume] in Urine
1299
10585
1.32
14.79
4.7
3.0
e6/l
39.5
57.3
1.08
939
6542
(3002385) Erythrocyte distribution width [Ratio]
3564
33135
1.35
14.77
15.9
10.7
%
13.3
13.2
2.21
3508
32489
(3016502) Oxygen saturation in Arterial blood
255
1511
1.73
14.62
8.7
8.9
%
96.5
96.7
0.25
242
1434
(3015377) Calcium [Moles/volume] in Serum or Plasma
987
7743
1.35
14.56
3.2
2.5
mmol/l
2.3
2.3
0.12
889
7033
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
166
865
1.95
14.40
9.9
10.8
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
901
6982
1.36
14.37
2.2
1.8
%
1.4
1.3
4.70
806
6417
(3007461) Platelets [#/volume] in Blood
4416
42859
1.95
14.35
19.0
12.8
e9/l
263.0
260.3
2.33
4342
41999
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
740
5566
1.39
14.16
2.4
2.5
u/l
7689.9
6864.6
0.25
267
2412
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
570
4102
1.45
13.99
3.1
2.2
e6/l
0.8
1.1
0.70
311
2123
(3014576) Chloride [Moles/volume] in Serum or Plasma
339
2189
1.59
13.92
8.4
7.3
mmol/l
104.0
105.0
3.88
329
2146
(3026361) Erythrocytes [#/volume] in Blood
4421
42954
1.95
13.85
19.0
12.8
e12/l
4.6
4.6
1.36
4339
42063
(3000963) Hemoglobin [Mass/volume] in Blood
4423
42983
1.96
13.80
19.1
12.9
g/l
137.6
138.1
1.78
4381
42584
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
339
2196
1.59
13.73
1.9
1.6
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
64
225
2.87
13.66
1.4
1.3
—
—
—
0
0
(3035941) MCH [Entitic mass]
4419
42941
1.93
13.64
18.9
12.7
pg
29.9
29.9
0.01
4377
42549
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
111
508
2.21
13.63
8.0
3.5
nmol/l
1.1
0.9
1.79
94
438
(3024731) MCV [Entitic volume]
4419
42944
1.93
13.59
18.9
12.7
fl
89.2
89.0
2.40
4378
42553
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
930
7300
1.34
13.54
2.3
2.1
mg/l
2.7
2.5
1.13
789
6313
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
554
3989
1.44
13.54
3.2
2.3
e6/l
4.6
3.9
0.57
299
2004
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
86
353
2.46
13.54
4.3
4.9
u/ml
0.3
0.3
1.20
37
181
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
355
2334
1.56
13.49
3.2
2.4
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
4421
42979
1.93
13.44
19.1
12.8
e9/l
7.2
6.8
27.78
4341
42058
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
345
2260
1.57
13.32
1.8
1.6
—
—
—
0
0
(3044889) 12 lead EKG panel
2036
17746
1.27
13.31
2.7
2.3
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
880
6867
1.35
13.30
5.1
3.5
%
97.3
96.5
0.51
850
6658
(3027273) Bicarbonate [Moles/volume] in Venous blood
140
711
2.00
13.11
4.3
3.8
mmol/l
24.5
24.8
0.65
135
682
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1628
13856
1.27
12.84
3.6
2.8
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
1780
15317
1.27
12.80
2.4
2.3
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
13
11
11.85
12.63
3.1
4.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
1630
13902
1.27
12.56
2.3
2.2
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
236
1428
1.69
12.56
8.9
9.3
g/l
121.1
126.2
2.69
225
1362
(3013512) EKG study
669
5044
1.38
12.51
2.8
2.2
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
270
1695
1.63
12.46
8.2
7.1
mmol/l
1.2
1.4
1.25
264
1622
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
105
489
2.17
12.38
1.4
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
3537
33089
1.31
12.34
3.4
2.8
mmol/l
2.9
2.9
0.18
3324
31552
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
183
1039
1.79
12.20
2.0
1.4
u/ml
118.5
101.5
1.44
34
238
(3011648) Oxygen content in Venous blood
48
155
3.12
11.92
3.9
3.9
%
11.9
11.9
0.02
48
155
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
127
645
2.00
11.92
4.8
2.7
mmol/l
24.1
24.3
0.37
120
606
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
187
1079
1.76
11.81
2.0
1.3
u/ml
20.5
18.2
—
6
27
(3023511) Choriogonadotropin [Units/volume] in Urine
398
2759
1.48
11.80
1.5
1.4
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
129
664
1.97
11.67
5.3
5.2
mmol/l
1.3
1.2
0.68
114
559
(4035726)
239
1488
1.64
11.41
1.6
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
934
7500
1.31
11.36
8.6
6.5
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
116
583
2.02
11.23
5.9
5.9
umol/l
392.9
372.1
0.77
101
510
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2996
27585
1.25
11.15
3.4
2.6
u/l
37.1
31.8
5.94
2881
26632
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
186
1098
1.72
10.87
2.0
1.4
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
258
1657
1.59
10.86
4.7
2.9
mmol/l
1.2
1.2
0.73
233
1413
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
145
796
1.85
10.83
10.0
11.0
mmol/l
23.4
23.8
0.67
135
749
(44816559) Phosphatidylethanol [Mass/volume] in Blood
189
1123
1.71
10.79
1.7
1.4
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
115
586
1.99
10.73
6.2
5.9
%
0.9
1.0
0.64
106
534
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
115
589
1.98
10.58
5.9
5.9
%
2.2
1.9
1.47
106
534
(3015235) Bicarbonate [Moles/volume] in Capillary blood
96
465
2.09
10.30
3.7
2.4
mmol/l
23.3
23.7
0.37
84
416
(3004809) Band form neutrophils/100 leukocytes in Blood
69
292
2.38
10.26
3.1
2.4
%
0.9
1.2
0.76
48
235
(3028626) Oxygen [Partial pressure] in Capillary blood
93
446
2.11
10.25
5.5
2.3
kpa
9.3
9.2
0.00
88
418
(3020630) Protein [Mass/volume] in Serum or Plasma
173
1019
1.73
10.21
2.2
1.8
g/l
67.3
67.8
0.37
165
967
(3011397) Hemoglobin [Presence] in Urine by Test strip
919
7463
1.29
10.14
3.6
2.9
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
119
627
1.92
10.10
2.7
2.5
ug/l
270.8
783.3
0.65
107
556
(3019060) Gas panel - Arterial blood
158
914
1.75
9.95
5.0
5.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
729
5767
1.31
9.76
1.3
1.3
iu/ml
24.5
19.5
0.69
199
1596
(3042517) Benzodiazepines panel - Urine
43
147
2.94
9.75
4.0
2.7
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
113
593
1.93
9.73
1.6
1.3
ug/g
300.2
322.2
0.52
73
278
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
73
325
2.27
9.69
2.4
1.8
iu/ml
394116.7
2066291.6
—
9
34
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1281
10881
1.25
9.63
1.4
1.3
u/ml
1.3
1.6
0.55
364
3152
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
32
93
3.46
9.45
1.8
1.6
u/l
5.2
3.1
0.32
18
49
(3021901) Oxygen saturation in Capillary blood
71
317
2.26
9.37
2.9
2.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
883
7201
1.28
9.34
2.1
1.9
mg/l
1.0
0.9
0.27
616
4899
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
120
654
1.86
9.23
1.5
1.6
mmol/l
10.5
11.6
0.43
23
70
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
340
2400
1.45
9.19
4.5
3.8
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
255
1699
1.53
9.17
2.7
2.1
ml/min/173m2
77.0
87.9
1.97
82
602
(3005719) IgG [Mass/volume] in Serum or Plasma
358
2555
1.44
9.12
2.8
2.4
g/l
10.6
10.5
0.26
338
2358
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
3494
32996
1.25
9.10
3.4
2.7
mmol/l
4.7
4.7
0.29
3328
31708
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
382
2761
1.42
9.08
3.9
2.5
u/l
38.9
52.8
0.36
338
2366
(3048929) Epstein Barr virus Ab [Presence] in Serum
345
2451
1.44
9.01
1.4
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
672
5320
1.31
8.90
1.3
1.3
u/ml
9.3
7.9
0.27
264
2248
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
94
480
1.98
8.79
1.9
1.9
ug/l
1.1
1.6
0.61
86
419
(3000764) Benzodiazepines [Presence] in Urine
646
5096
1.31
8.77
2.9
2.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
649
5138
1.31
8.57
3.0
2.4
—
—
—
0
0
(3019225) pH of Specimen
268
1833
1.49
8.52
5.4
2.9
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
3470
32819
1.24
8.49
3.3
2.7
mmol/l
1.3
1.4
21.14
3300
31531
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
496
3794
1.34
8.33
3.1
2.4
ng/l
371.5
393.4
0.06
216
1581
(3039000) Anion gap in Blood
76
367
2.09
8.30
7.3
7.8
mmol/l
11.9
11.5
0.51
68
320
(3018572) Chloride [Moles/volume] in Blood
76
368
2.08
8.25
7.3
7.8
mmol/l
105.5
105.6
0.03
68
321
(3037522) Nuclear Ab [Titer] in Serum
633
5024
1.30
8.19
1.4
1.4
titre
522.4
532.9
0.04
117
849
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
191
1224
1.58
8.19
1.5
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
3333
31431
1.22
8.17
3.1
2.5
mmol/l
1.3
1.2
13.65
3172
30229
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
184
1171
1.60
8.12
1.5
1.3
u/ml
240.4
234.6
0.11
135
775
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
85
433
1.98
8.04
3.0
2.8
ug/min
299.2
150.6
0.93
71
292
(3016879) Cocaine [Presence] in Urine
604
4782
1.30
7.95
3.0
2.4
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
155
951
1.65
7.94
6.7
7.3
mmol/l
23.3
23.9
0.92
141
874
(3036481) Cortisol [Moles/volume] in Serum or Plasma
435
3286
1.36
7.93
2.2
1.9
nmol/l
365.9
385.8
1.39
404
3026
(3027008) Opiates [Presence] in Urine
641
5128
1.29
7.79
2.9
2.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
515
4015
1.32
7.58
3.1
2.5
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
34
118
2.90
7.57
1.9
5.0
mg/l
70.7
7028.1
1.35
22
80
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
75
375
2.02
7.50
3.0
2.4
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
180
1163
1.57
7.48
3.3
2.4
e6/l
0.2
0.2
0.43
172
1111
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
134
805
1.68
7.46
1.2
1.3
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
49
208
2.37
7.34
5.7
7.0
mg/l
9.4
9.2
0.15
44
192
(4198724)
97
535
1.83
7.27
3.1
3.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
1246
10813
1.21
7.23
3.1
2.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
150
936
1.62
7.22
4.0
3.0
g/l
0.8
0.3
1.47
97
476
(3004588) Protein electrophoresis panel - Serum or Plasma
119
699
1.72
7.21
1.4
1.4
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
48
204
2.37
7.18
1.6
1.8
mg/l
61.3
34.5
1.61
36
170
(3027944) Amphetamines [Presence] in Urine
626
5058
1.28
7.01
2.9
2.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
1801
16203
1.18
6.94
2.0
1.8
—
—
—
0
0
(4010399)
231
1603
1.46
6.88
1.3
1.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
1181
10238
1.21
6.88
2.5
1.9
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
70
353
2.00
6.87
1.3
1.4
g/l
10.5
10.7
0.14
64
307
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
143
895
1.62
6.82
3.1
2.6
ng/l
108.9
75.7
0.56
119
740
(40768804) Tissue Pathology biopsy report
1376
12106
1.20
6.82
1.9
1.8
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
61
294
2.09
6.77
1.3
1.3
g/l
38.2
39.9
1.03
56
267
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
74
383
1.95
6.76
1.3
1.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
74
383
1.95
6.76
1.3
1.4
g/l
3.6
3.7
0.22
60
275
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
47
204
2.32
6.73
1.7
1.8
mg/l
48.4
27.6
1.43
35
170
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
74
384
1.94
6.71
1.3
1.4
g/l
7.5
7.0
1.62
63
298
(3028026) IgM [Mass/volume] in Serum or Plasma
268
1922
1.42
6.70
1.6
1.8
g/l
1.2
1.3
0.98
249
1801
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
117
701
1.69
6.62
1.1
1.2
iu/ml
61.1
2234.7
0.93
41
215
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
144
910
1.60
6.62
2.4
2.7
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
44
188
2.35
6.54
1.3
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
2178
19974
1.17
6.51
2.3
2.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
56
266
2.12
6.47
1.1
1.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
293
3934
0.73
6.41
1.5
1.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
179
1198
1.51
6.40
1.7
1.5
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
71
371
1.93
6.33
1.3
1.4
g/l
3.3
3.0
1.12
61
294
(3017354) Segmented neutrophils/100 leukocytes in Blood
41
173
2.38
6.28
2.7
2.3
%
52.7
56.4
0.44
24
113
(3023183) Ammonium ion [Moles/volume] in Plasma
75
402
1.88
6.20
2.5
2.8
umol/l
29.6
32.4
0.76
65
353
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
571
4629
1.27
6.20
1.5
1.5
pmol/l
156914245.9
24684274.5
1.73
499
4112
(40761535) Cells panel - Urine sediment
246
1763
1.42
6.20
3.5
2.9
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
154
1005
1.55
6.19
1.2
1.2
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
43
187
2.31
6.16
3.0
2.5
umol/l
162.4
144.5
0.13
20
85
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
154
2304
0.66
6.15
1.2
1.2
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
47
213
2.22
6.12
1.2
1.5
nmol/l
1.4
1.4
0.15
42
192
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
180
1222
1.49
6.03
3.3
2.9
g/l
3.5
3.6
0.53
168
1151
(3025941) Bacteria identified in Stool by Culture
342
2599
1.34
6.02
1.3
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
208
1454
1.45
6.01
1.9
1.7
iu/ml
1.8
0.4
0.45
41
295
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
56
275
2.05
5.96
1.1
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
188
1291
1.48
5.95
1.9
1.9
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
65
337
1.94
5.95
1.4
1.2
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
183
1252
1.48
5.91
2.6
2.5
%
95.8
94.9
0.17
166
1139
(40767503) Oxygen content in Capillary blood by calculation
79
438
1.82
5.90
3.0
1.8
%
17.3
18.0
0.96
41
195
(3005033) Fetal Nuchal fold Thickness US
297
3923
0.74
5.84
1.5
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
378
2928
1.32
5.84
1.5
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
38
161
2.37
5.79
1.6
1.8
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
25
86
2.92
5.72
1.8
1.9
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
307
4021
0.75
5.70
1.6
1.5
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
250
1829
1.39
5.62
1.1
1.1
u/ml
1.2
12.3
—
5
21
(3007566) Smooth muscle Ab [Titer] in Serum
152
1012
1.52
5.61
1.2
1.4
titre
83.8
79.7
0.09
13
114
(3016650) Hepatitis A virus Ab [Presence] in Serum
126
805
1.58
5.59
1.2
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
485
3904
1.27
5.58
1.2
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
1049
9147
1.19
5.57
1.4
1.4
g/l
2.2
2.1
2.75
653
6022
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
153
1022
1.51
5.57
1.1
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
754
6376
1.22
5.55
2.8
2.8
ug/g
134.3
111.1
1.04
601
5059
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
874
7516
1.20
5.39
2.6
1.8
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
43
199
2.17
5.36
1.7
1.7
ratio
1.5
1.2
—
5
30
(3006184) Hemoglobin [Mass/volume] in Capillary blood
84
489
1.73
5.35
2.4
2.0
g/l
133.6
136.8
0.82
72
379
(3013139) Helicobacter pylori Ag [Presence] in Stool
287
2164
1.35
5.35
1.3
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
331
2551
1.32
5.32
3.1
2.4
%
29.2
31.4
3.03
266
2004
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
79
453
1.76
5.31
12.6
11.6
mmol/l
0.6
0.6
0.10
71
416
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
154
1041
1.50
5.31
1.8
1.4
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
20
63
3.18
5.31
1.8
1.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
215
1551
1.41
5.26
10.1
7.0
inr
1.1
1.1
0.21
50
307
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
425
3396
1.28
5.20
2.4
2.2
mmol/l
2.4
2.4
3.75
345
2903
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
388
4853
0.78
5.10
1.4
1.4
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
13
31
4.20
5.09
26.3
7.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
149
1010
1.49
5.09
2.2
1.9
—
—
—
0
0
(3012501) Base excess in Blood by calculation
92
559
1.66
5.04
4.6
2.6
mmol/l
1.6
1.9
1.02
56
315
(3008757) Leukocyte morphology finding [Identifier] in Blood
42
198
2.13
5.03
4.0
2.5
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
37
166
2.24
4.99
10.7
7.9
u/ml
336.5
14384.0
0.51
20
46
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
115
740
1.57
4.99
1.2
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
106
670
1.60
4.96
1.7
1.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
99
616
1.62
4.94
1.6
1.3
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
162
1126
1.45
4.89
2.3
1.8
u/ml
13.0
9.9
—
7
64
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
351
2761
1.29
4.87
2.2
2.1
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
21
72
2.93
4.86
1.3
1.5
e6/l
3583.8
3398.6
0.07
13
46
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
21
72
2.93
4.86
2.6
2.2
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
12
28
4.29
4.82
27.3
7.9
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
20
67
2.99
4.82
1.3
1.5
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
52
270
1.94
4.81
1.2
1.2
u/l
84.3
35.6
0.47
44
238
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
394
4884
0.79
4.80
1.4
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
308
3936
0.77
4.80
1.2
1.2
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
394
4880
0.79
4.77
1.4
1.5
—
—
—
0
0
(3036489) Thrombin time
193
1392
1.40
4.76
2.5
2.3
s
21.4
20.6
1.47
158
1144
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
70
401
1.76
4.76
1.4
1.5
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
27
615
0.44
4.70
1.4
1.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
41
197
2.09
4.70
1.6
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
460
5580
0.80
4.63
1.3
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
208
1529
1.38
4.60
1.5
1.5
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
20
69
2.91
4.59
1.6
1.6
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
34
153
2.23
4.58
3.2
3.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
1026
9061
1.17
4.58
5.5
4.0
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
395
4866
0.79
4.57
1.4
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
66
377
1.76
4.55
1.7
1.6
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
51
269
1.91
4.53
3.3
6.4
mmol/l
7.9
6.6
1.25
42
219
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
17
54
3.16
4.48
1.2
2.1
ng/l
95.9
20.1
0.67
11
27
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
133
906
1.48
4.48
2.1
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
24
93
2.59
4.46
2.2
1.8
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
827
7191
1.18
4.45
2.0
1.9
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
64
366
1.76
4.41
1.6
1.9
mu/l
81.8
65.3
0.32
56
325
(3052851) Hemolysis interference index of Serum or Plasma
113
749
1.52
4.35
2.5
2.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
84
520
1.63
4.33
1.9
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
372
2994
1.26
4.32
1.4
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
428
5190
0.81
4.29
1.5
1.5
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
58
325
1.79
4.29
1.2
1.2
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
166
1192
1.41
4.24
3.2
2.8
%
179.5
160.0
2.04
159
1124
(40768443) Skin Pathology biopsy report
152
1075
1.43
4.23
1.2
1.1
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
119
803
1.49
4.22
2.2
1.7
titre
3680.0
5089.2
—
6
26
(3010421) pH of Blood
100
650
1.55
4.21
4.6
2.9
ph
7.4
7.4
0.97
91
548
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
42
213
1.98
4.20
1.7
1.7
%
40.8
48.2
0.56
31
142
(3028308) Erythrocytes [#/volume] in Pleural fluid
18
62
2.91
4.16
1.4
1.6
e6/l
18787.9
12870.1
0.19
11
34
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
36
173
2.09
4.16
3.2
2.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
68
403
1.70
4.15
1.9
1.6
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
64
373
1.73
4.15
1.1
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
1084
9682
1.16
4.13
1.7
1.6
—
—
—
0
0
(3000492) Spirometry study
477
3979
1.22
4.01
1.4
1.3
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
27
117
2.32
4.00
2.6
2.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
23
93
2.48
3.96
2.2
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
23
93
2.48
3.96
2.2
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
23
93
2.48
3.96
2.2
1.8
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
66
394
1.69
3.94
1.5
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
1038
9272
1.15
3.93
2.2
2.0
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
692
5988
1.18
3.93
1.7
1.5
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
31
144
2.16
3.92
2.5
3.8
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
31
145
2.15
3.85
1.2
1.4
pmol/l
13.5
13.4
0.07
22
125
(3003694) ABO and Rh group [Type] in Blood
1654
15262
1.13
3.84
1.8
1.9
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
272
3427
0.78
3.82
1.4
1.5
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
17
60
2.84
3.79
1.5
1.6
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
48
267
1.81
3.68
3.3
2.9
e6/l
756.3
881.6
0.64
17
109
(3003181) Sodium [Moles/volume] in Urine
37
189
1.97
3.67
1.4
1.6
mmol/l
85.8
74.3
0.43
29
149
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
36
183
1.97
3.62
1.1
1.1
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
25
110
2.28
3.61
1.1
1.2
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
18
68
2.65
3.56
3.9
6.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
53
309
1.72
3.49
1.1
1.1
miu/ml
1629.8
1446.7
0.49
53
309
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
58
347
1.68
3.48
1.2
1.6
pmol/l
324.2
401.1
0.87
44
261
(3035320) C reactive protein [Mass/volume] in Body fluid
43
236
1.83
3.46
2.9
2.1
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
31
152
2.05
3.45
3.3
3.7
mg/l
259.0
49.2
1.38
25
114
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
76
489
1.56
3.42
1.3
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
76
489
1.56
3.42
1.3
1.1
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
132
950
1.40
3.40
1.4
1.4
u/l
13.9
11.1
0.84
117
816
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
49
282
1.75
3.38
1.1
1.2
u/ml
1.4
14.3
—
5
36
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
47
268
1.76
3.35
1.0
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
107
745
1.45
3.32
4.7
3.7
%
58.5
56.2
1.65
107
745
(21494815) CD4 cells/100 lymphocytes in Specimen
55
329
1.68
3.32
3.0
2.4
%
35.3
45.6
—
6
54
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
119
849
1.41
3.24
2.8
4.1
ug/l
7.6
61.0
0.56
84
537
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
21
90
2.34
3.24
8.6
8.6
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
28
136
2.07
3.21
1.6
2.3
nmol/l
1.4
1.4
0.03
21
112
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
14
49
2.86
3.19
1.5
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
81
539
1.51
3.16
4.9
2.6
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
105
737
1.43
3.14
4.3
3.5
e9/l
4.6
3.9
2.25
105
737
(3002256) Pathology report gross observation
415
3505
1.20
3.11
1.2
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
46
267
1.73
3.11
2.0
1.7
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
391
3285
1.21
3.10
1.2
1.2
—
—
—
0
0
(3017704) Immunofixation for Urine
14
50
2.81
3.08
1.6
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
78
519
1.51
3.06
2.0
1.6
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
6
8
7.51
3.05
2.3
10.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
29
146
1.99
3.04
2.0
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
29
146
1.99
3.04
2.0
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
29
146
1.99
3.04
2.0
1.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
1535
14260
1.12
3.01
1.8
1.7
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
74
489
1.52
3.00
1.2
1.2
—
200.0
—
0
11
(3014891) Appearance of Pleural fluid
5
5
10.01
2.98
1.8
1.6
—
—
—
0
0
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
5
5
10.01
2.98
2.6
5.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
146
1098
1.34
2.92
2.5
2.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
35
191
1.84
2.92
2.6
3.4
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
13
46
2.83
2.91
1.0
1.0
umol/24h
0.6
0.7
—
7
30
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
65
421
1.55
2.89
6.4
2.9
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
48
289
1.67
2.87
1.9
1.6
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
46
274
1.69
2.86
2.9
2.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
72
479
1.51
2.85
1.4
1.3
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
57
360
1.59
2.83
3.4
2.6
e9/l
1.3
1.3
0.06
35
196
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
148
1123
1.33
2.80
2.9
1.9
g/l
0.2
0.2
1.58
141
1074
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
16
65
2.47
2.78
3.7
2.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
16
65
2.47
2.78
3.7
2.1
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
29
152
1.91
2.74
1.1
1.3
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
46
278
1.66
2.73
2.3
2.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
7
14
5.01
2.72
1.0
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
28
146
1.92
2.69
1.6
1.4
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
23
112
2.06
2.66
1.0
1.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
330
2776
1.20
2.62
1.4
1.3
u/ml
208.4
264.0
0.75
300
2582
(3001122) Ferritin [Mass/volume] in Serum or Plasma
2098
19910
1.10
2.61
3.5
2.9
ug/l
82.3
66.6
2.88
1974
19008
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
7
15
4.67
2.59
5.7
8.2
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
149
1146
1.31
2.59
2.9
1.8
g/l
1.2
1.1
1.29
143
1096
(3009542) Hematocrit [Volume Fraction] of Blood
3899
38203
1.14
2.57
13.9
9.3
%
40.8
40.9
0.65
3228
32905
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
19
87
2.19
2.57
1.8
2.8
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
384
3285
1.18
2.54
2.1
2.2
nmol/l
12.1
12.3
0.19
337
3005
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
34
194
1.76
2.50
1.1
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
314
2644
1.20
2.48
1.7
1.7
ug/l
0.8
0.9
3.43
286
2438
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
11
39
2.82
2.47
1.3
1.6
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
11
39
2.82
2.47
2.2
4.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
24
123
1.96
2.45
2.3
2.7
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
824
9062
0.89
2.43
1.5
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
54
351
1.54
2.42
1.9
1.4
—
—
—
0
0
(3025315) Body weight
8
22
3.64
2.36
5.1
2.8
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
7
17
4.12
2.36
5.0
8.3
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
7
17
4.12
2.36
1.1
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
32
183
1.75
2.35
1.5
1.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
51
330
1.55
2.34
2.1
1.7
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
91
661
1.38
2.33
1.9
2.4
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
47
299
1.58
2.32
2.9
2.2
%
16.0
12.7
0.34
21
180
(3025468) Yersinia sp identified in Specimen by Organism specific culture
53
347
1.53
2.32
1.9
1.4
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
24
126
1.91
2.30
1.5
1.5
e6/l
4755.3
33857.6
0.86
16
81
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
48
308
1.56
2.29
1.6
1.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
13
53
2.46
2.27
1.3
1.5
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
13
4.62
2.27
4.2
3.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
53
349
1.52
2.26
1.9
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
53
349
1.52
2.26
1.9
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
54
359
1.51
2.21
1.9
1.4
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
36
217
1.66
2.21
1.6
1.9
mosm/kgh2o
290.6
288.0
0.24
30
170
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
28
157
1.79
2.21
1.1
1.2
g/l
0.3
0.3
1.00
21
121
(1761868) Lipid panel - Serum or Plasma
1344
14344
0.91
2.21
2.1
1.9
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
24
128
1.88
2.21
2.8
2.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
21
107
1.97
2.20
1.4
1.2
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
65
450
1.45
2.19
1.0
1.1
g/l
1.4
1.4
0.37
60
407
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
12
48
2.50
2.18
1.6
1.3
pmol/l
501.9
252.6
—
7
34
(3037692) Legionella sp identified in Specimen by Organism specific culture
12
48
2.50
2.18
1.3
1.6
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
11
42
2.62
2.18
1.2
1.2
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
35
563
0.62
2.16
1.1
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
6
14
4.29
2.15
1.0
1.3
—
—
—
0
0
(3048879) Bone marrow aspiration report
7
19
3.69
2.15
3.6
3.7
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
7
19
3.69
2.15
3.9
2.9
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
16
74
2.17
2.14
2.8
2.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
81
588
1.38
2.11
1.1
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
74
529
1.41
2.11
1.5
1.3
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
15
68
2.21
2.10
1.1
1.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
15
68
2.21
2.10
3.1
2.6
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
22
116
1.90
2.10
1.0
1.1
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
8
25
3.20
2.09
1.3
1.1
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
53
356
1.49
2.09
1.5
1.3
—
24.6
—
0
7
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
5
10
5.00
2.07
57.6
7.6
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
17
82
2.08
2.06
1.5
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
17
82
2.08
2.06
1.5
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
846
9205
0.90
2.04
1.5
1.5
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
26
147
1.77
2.02
1.9
1.6
%
46.2
40.0
0.30
17
95
(3035880) pH of Pleural fluid
8
26
3.08
2.01
1.1
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
124
969
1.29
1.99
1.8
1.8
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
51
344
1.49
1.98
1.4
1.3
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
7
21
3.34
1.96
4.1
2.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
152
1221
1.25
1.95
1.3
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
17
84
2.03
1.95
1.9
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
17
84
2.03
1.95
1.9
1.5
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
17
84
2.03
1.95
1.3
1.2
u/l
77.7
76.4
0.04
11
73
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
20
105
1.91
1.95
1.5
1.2
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
106
814
1.31
1.94
1.7
2.1
mg/l
11.2
9.6
0.89
99
777
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
158
1276
1.25
1.94
2.0
2.0
u/l
40.0
40.0
0.01
151
1216
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
5
11
4.55
1.94
2.0
3.6
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
14
64
2.19
1.94
1.3
1.2
—
35.0
—
0
6
(3020891) Body temperature
83
615
1.36
1.94
4.4
5.0
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
6
16
3.75
1.93
3.8
3.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
55
380
1.45
1.91
1.6
1.8
e6/l
7330.6
14130.5
1.29
45
280
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
182
2203
0.82
1.91
1.3
1.2
ug/l
2.9
3.4
1.43
172
2113
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
34
211
1.62
1.91
3.5
2.6
%
34.1
44.2
1.75
12
81
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
66
473
1.40
1.89
1.1
1.1
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
163
1326
1.24
1.89
1.6
1.7
mmol/l
7.8
7.4
0.79
79
809
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
229
1928
1.20
1.88
1.4
1.4
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
7
22
3.19
1.88
1.0
1.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
36
228
1.58
1.87
1.1
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
28
166
1.69
1.87
1.1
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
37
236
1.57
1.86
1.9
1.6
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
16
79
2.03
1.85
1.4
1.7
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
447
3973
1.14
1.84
1.7
1.8
—
—
—
0
0
(4146454)
22
122
1.81
1.83
4.0
3.0
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
7
23
3.05
1.80
2.0
1.0
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
42
279
1.51
1.78
1.1
1.4
—
193.3
—
0
9
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
53
370
1.44
1.77
1.2
1.6
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
15
74
2.03
1.74
2.9
1.9
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
15
74
2.03
1.74
2.9
1.9
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
12
54
2.23
1.73
1.1
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
12
54
2.23
1.73
1.1
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
12
54
2.23
1.73
1.1
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
12
54
2.23
1.73
1.1
1.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
305
2652
1.16
1.73
3.3
3.4
pmol/l
4.9
4.7
1.09
275
2403
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
5
13
3.85
1.71
1.0
1.1
mmol/l
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
143
1162
1.24
1.70
1.2
1.1
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
16
82
1.95
1.69
1.3
1.2
u/l
14.1
14.4
—
10
67
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
43
291
1.48
1.69
1.9
2.0
%
100.6
99.5
0.07
38
259
(3024522) Salmonella sp identified in Specimen by Organism specific culture
50
349
1.44
1.68
1.9
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
272
2350
1.17
1.68
1.8
1.9
e9/l
4.3
4.3
0.01
227
2034
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
55
392
1.41
1.66
1.6
1.4
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
110
870
1.27
1.66
1.2
1.5
e6/l
630.1
4594.2
0.46
94
711
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
209
1770
1.19
1.65
1.4
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
143
1167
1.23
1.65
1.2
1.1
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
110
871
1.27
1.64
1.1
1.5
e6/l
10.5
24.9
1.32
89
681
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
14
69
2.03
1.64
4.1
2.8
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
393
3494
1.14
1.64
4.4
3.0
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
11
49
2.25
1.63
1.0
1.1
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
217
1846
1.18
1.63
2.3
2.3
umol/l
4.2
5.3
2.09
158
1377
(3025886) Oxalate [Mass/time] in 24 hour Urine
5
14
3.57
1.61
1.2
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
340
3000
1.14
1.59
1.1
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
94
734
1.29
1.58
1.1
1.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
6
20
3.00
1.58
2.0
2.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
21
121
1.74
1.58
7.1
4.5
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
7
26
2.69
1.58
5.0
2.8
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
7
26
2.69
1.58
1.0
1.2
—
—
—
0
0
(4306422)
96
752
1.28
1.58
1.2
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
18
99
1.82
1.57
1.1
1.0
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
40
272
1.47
1.56
1.7
1.3
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
5
15
3.34
1.52
1.8
2.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
140
1152
1.22
1.51
1.2
1.1
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
16
86
1.86
1.50
1.8
1.4
%
6.4
5.1
—
5
22
(21494755) Public health laboratory ask at order entry panel
680
7359
0.91
1.48
1.3
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
40
276
1.45
1.46
1.6
1.5
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
19
109
1.75
1.46
1.6
1.7
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
296
3352
0.87
1.45
1.4
1.5
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
6
22
2.73
1.43
1.0
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
22
133
1.66
1.42
2.2
1.8
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
16
88
1.82
1.41
1.0
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
174
1476
1.19
1.39
1.6
1.7
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
7
29
2.42
1.39
1.0
1.1
umol/24h
1.3
1.8
—
7
29
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
11
53
2.08
1.38
1.0
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
11
53
2.08
1.38
1.0
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
20
323
0.62
1.36
1.3
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
155
1306
1.19
1.34
1.8
1.6
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
95
761
1.25
1.34
1.3
1.3
u/ml
3.1
4.0
0.72
52
338
(40761995) Spermatozoa Progressive [#/volume] in Semen
38
536
0.71
1.34
3.5
3.4
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
38
536
0.71
1.34
7.0
6.7
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
21
128
1.64
1.33
1.5
1.5
nmol/l
136.8
131.8
0.25
21
128
(3005011) Chlamydia sp Ab [Titer] in Serum
12
61
1.97
1.32
1.4
1.5
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
168
1429
1.18
1.32
1.3
1.3
u/ml
0.3
1.2
—
10
98
(3004982) Buprenorphine [Mass/volume] in Serum or Plasma
6
24
2.50
1.30
3.0
2.6
ug/l
2.5
2.0
—
6
18
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
88
702
1.26
1.30
1.1
1.1
%
118.8
114.8
0.64
78
634
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
64
490
1.31
1.29
1.3
1.2
umol/l
5.9
6.5
0.77
56
462
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
5
18
2.78
1.28
1.0
1.2
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
15
84
1.79
1.27
3.1
2.5
umol/l
30.5
27.2
—
9
65
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
395
3577
1.11
1.26
2.1
1.9
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
99
1211
0.81
1.25
1.1
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
30
203
1.48
1.24
2.3
1.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
251
2214
1.14
1.24
1.1
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
9
45
2.00
1.23
3.9
3.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
34
237
1.44
1.22
1.6
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
56
425
1.32
1.22
1.1
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
101
826
1.23
1.21
1.2
1.5
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
58
443
1.31
1.21
2.2
1.7
iu/ml
57.7
27.4
—
6
24
(3019832) Treponema pallidum Ab [Presence] in Serum
1501
14392
1.06
1.20
1.8
1.7
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
183
1582
1.16
1.20
1.1
1.1
u/ml
3.9
4.2
0.09
16
277
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
22
140
1.57
1.20
1.6
1.3
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
30
205
1.47
1.19
1.2
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
690
6438
1.08
1.19
2.1
2.2
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
6
26
2.31
1.18
6.8
1.3
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
63
489
1.29
1.18
1.1
1.1
%
94.8
93.4
0.16
58
457
(3003740) Influenza virus B Ag [Presence] in Specimen
100
1212
0.82
1.17
1.1
1.1
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
80
643
1.25
1.14
1.3
1.3
u/ml
2.9
7.7
—
8
38
(3020961) Endomysium IgA Ab [Titer] in Serum
276
2466
1.13
1.14
1.1
1.1
titre
164.3
239.2
—
7
69
(3005082) Progesterone [Moles/volume] in Serum or Plasma
76
943
0.80
1.12
1.5
1.4
nmol/l
30.5
32.4
0.26
69
869
(3021788) Differential panel - Synovial fluid
44
327
1.35
1.12
1.6
1.6
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
11
58
1.90
1.12
1.1
1.2
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
46
346
1.33
1.09
1.2
1.2
ratio
1.1
1.1
0.02
18
134
(3018405) Lactate [Moles/volume] in Arterial blood
66
522
1.27
1.09
3.5
4.1
mmol/l
1.6
1.4
0.72
66
516
(40757494) Bilirubin.total [Moles/volume] in Blood
18
112
1.61
1.08
1.9
2.2
—
15.1
—
0
21
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
101
838
1.21
1.08
1.3
1.3
u/ml
8.7
17.7
0.74
17
119
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
35
252
1.39
1.08
2.2
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
3729
37756
0.93
1.07
4.1
4.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
202
1779
1.14
1.06
1.9
1.7
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
7
33
2.12
1.05
1.6
1.5
—
—
—
0
0
(4268621)
69
552
1.25
1.04
2.2
2.3
—
—
—
0
0
(3013762) Body weight Measured
5
22
2.27
1.03
1.2
1.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
18
114
1.58
1.02
4.1
3.5
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
99
827
1.20
1.01
1.3
1.3
u/ml
5.8
5.3
0.06
15
72
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
9
48
1.88
1.00
1.1
1.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
7
35
2.00
1.00
2.4
3.7
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
7
35
2.00
1.00
2.9
1.5
ng/l
127.6
109.7
—
7
35
(3049717) Cytology report of Urine Cyto stain
38
282
1.35
1.00
1.8
1.6
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
16
99
1.62
0.99
1.7
1.5
—
—
—
0
0
(4211845)
25
172
1.46
0.99
2.2
2.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
568
6078
0.93
0.99
1.4
1.5
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
64
512
1.25
0.98
1.2
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
23
156
1.48
0.98
1.8
1.1
—
—
—
0
0
(44790048)
39
294
1.33
0.94
1.8
1.5
—
—
—
0
0
(44806118)
39
294
1.33
0.94
1.8
1.5
—
—
—
0
0
(44790047)
39
294
1.33
0.94
1.8
1.5
—
—
—
0
0
(44790049)
39
294
1.33
0.94
1.8
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
124
1437
0.86
0.92
1.3
1.5
ug/l
0.4
0.4
0.33
47
441
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
21
142
1.48
0.92
1.5
1.1
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
10
55
1.82
0.92
1.0
1.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
37
278
1.33
0.91
1.3
1.5
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
26
184
1.42
0.91
1.0
1.2
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
56
447
1.26
0.89
3.3
4.2
u/ml
3.8
4.9
0.82
49
362
(3043409) Potassium [Moles/volume] in Arterial blood
56
447
1.26
0.89
3.4
4.3
mmol/l
3.8
3.8
0.14
50
415
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
108
922
1.18
0.89
1.3
1.3
u/ml
37.5
37.6
—
5
63
(44813793)
42
324
1.30
0.88
1.1
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
43
334
1.29
0.86
1.5
1.1
—
—
—
0
0
(3012565) Volume of 24 hour Urine
19
128
1.49
0.85
2.4
2.0
ml
2066.3
2176.0
0.13
19
123
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
43
335
1.29
0.84
1.5
1.1
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
8
45
1.78
0.84
1.0
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
41
318
1.29
0.83
1.6
1.3
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
33
248
1.33
0.83
1.0
1.1
%
103.8
92.1
1.43
26
198
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
28
205
1.37
0.83
1.0
1.1
%
109.9
96.5
1.39
14
87
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
39
301
1.30
0.82
3.6
2.7
e6/l
653.7
549.3
0.90
33
240
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
322
2963
1.09
0.82
1.3
1.3
miu/ml
196.2
239.8
1.29
132
1465
(3028433) Virus identified in Specimen by Culture
15
97
1.55
0.81
1.5
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
21
147
1.43
0.80
1.1
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
27
198
1.37
0.80
1.1
2.1
—
—
—
0
0
(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.0
—
20.7
—
0
17
(3022670) pH of Venous cord blood
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
6
33
1.82
0.79
2.0
2.2
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
6
33
1.82
0.79
1.3
1.1
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
12
74
1.62
0.78
2.6
2.5
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
30
225
1.34
0.78
1.7
1.6
mg/l
14.4
26.0
1.59
11
65
(3042111) Morphology [Interpretation] in Bone marrow Narrative
25
182
1.38
0.77
2.1
2.3
—
—
—
0
0
(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum
0
27
0.00
0.77
0.0
1.0
—
0.5
—
0
13
(3006442) Creatine [Moles/volume] in Serum or Plasma
31
234
1.33
0.77
1.5
1.3
—
68.4
—
0
25
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
39
305
1.28
0.76
1.1
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
10
59
1.70
0.75
1.2
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
10
59
1.70
0.75
1.1
1.2
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
25
183
1.37
0.75
4.6
2.8
u/ml
17.0
27.2
0.65
25
174
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
12
75
1.60
0.74
2.6
2.5
mg/l
25.4
19.6
0.72
12
70
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
5
24
2.08
0.74
1.6
2.0
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
20
141
1.42
0.74
2.2
2.3
umol/l
26.2
26.8
0.11
20
136
(3006462) Nitrate [Presence] in Urine
22
158
1.39
0.74
2.3
2.0
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
25
184
1.36
0.73
2.0
2.0
umol/l
2.0
1.8
0.38
25
175
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
14
92
1.52
0.72
1.1
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
44
353
1.25
0.71
1.7
4.5
u/ml
244.6
128.5
0.23
37
298
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
29
220
1.32
0.71
1.0
1.1
%
101.4
96.6
0.52
14
95
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
32
410
0.78
0.70
1.1
1.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
90
777
1.16
0.69
1.3
1.3
u/ml
2.5
5.0
1.02
38
269
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
16
228
0.70
0.69
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
39
310
1.26
0.69
1.1
1.1
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
71
602
1.18
0.68
1.3
1.7
g/l
0.5
0.7
1.68
50
459
(3004451) EKG impression Narrative
7
42
1.67
0.68
1.0
1.2
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
37
463
0.80
0.67
1.1
1.0
u/ml
0.4
3.1
1.32
12
110
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
5
91
0.55
0.67
1.0
1.0
u/ml
0.0
0.2
—
5
69
(3023410) Appearance of Cerebral spinal fluid
51
420
1.22
0.67
1.2
1.8
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
26
197
1.32
0.65
1.8
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
23
171
1.35
0.65
1.9
1.6
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
7
44
1.59
0.65
1.1
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
11
70
1.57
0.65
1.1
1.7
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
36
286
1.26
0.65
1.4
1.4
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
15
103
1.46
0.65
1.6
1.5
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
14
95
1.48
0.64
1.1
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
41
333
1.23
0.62
1.4
1.3
—
—
—
0
0
(3000012) Reticulocyte production index
11
71
1.55
0.62
1.1
1.4
—
—
—
0
0
(3007456) Orange IgE Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.1
—
0.2
—
0
8
(3036071) Salmonella sp Ab [Titer] in Serum
22
165
1.33
0.60
1.1
1.1
—
—
—
0
0
(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.0
—
0.2
—
0
10
(21494434) Karyotype in Bone marrow
15
105
1.43
0.60
1.6
1.3
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
36
444
0.81
0.59
1.1
1.0
u/ml
0.3
4.0
1.17
12
123
(3013293) Extractable nuclear Ab [Presence] in Serum
8
52
1.54
0.59
1.3
1.7
—
—
—
0
0
(3020093) Fractional oxyhemoglobin in Venous cord blood
0
22
0.00
0.59
0.0
1.1
—
70.7
—
0
22
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
21
157
1.34
0.59
1.1
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
16
114
1.40
0.58
1.1
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
41
336
1.22
0.58
1.1
1.1
—
—
—
0
0
(4024509)
28
219
1.28
0.58
1.3
1.4
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
6
35
1.72
0.57
1.5
1.3
—
—
—
0
0
(4034850)
73
839
0.87
0.56
8.8
6.6
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
59
503
1.18
0.56
1.1
1.2
mg/l
35.0
37.6
0.26
52
419
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
27
212
1.28
0.55
2.1
2.3
mg/l
7.8
9.5
1.02
22
175
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
21
159
1.32
0.55
1.6
2.1
umol/l
12.9
13.6
0.12
21
159
(4027681)
49
412
1.19
0.55
1.2
1.2
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
6
38
1.58
0.54
1.0
1.1
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
12
82
1.46
0.54
1.0
1.0
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
24
186
1.29
0.54
2.6
1.4
u/l
10.6
5.9
0.66
19
163
(3028679) Herpes simplex virus Ab [Presence] in Serum
33
405
0.81
0.54
1.2
1.2
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
85
961
0.88
0.53
1.1
1.1
u/ml
0.4
0.4
0.03
25
216
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
41
491
0.83
0.53
1.3
1.3
pmol/l
76.3
65.6
—
8
128
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
13
91
1.43
0.53
1.5
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
29
360
0.80
0.52
1.7
2.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
19
249
0.76
0.52
1.1
1.2
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
6
98
0.61
0.52
1.2
1.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
6
40
1.50
0.51
1.0
1.2
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
9
64
1.41
0.51
1.1
1.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
290
2724
1.07
0.51
1.8
1.4
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
39
467
0.83
0.51
1.3
1.3
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
11
75
1.47
0.50
1.0
1.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
3569
35388
1.04
0.50
16.2
10.6
g/l
334.2
334.8
3.46
3545
35080
(3029396) Erythrocyte agglutination [Presence] in Blood
40
476
0.84
0.49
2.8
3.0
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
7
45
1.56
0.49
1.0
1.6
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
7
45
1.56
0.49
1.0
1.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
7
47
1.49
0.47
1.0
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
107
1182
0.90
0.47
1.1
1.1
u/ml
4.4
5.1
0.13
53
509
(44806071)
10
68
1.47
0.47
1.1
1.0
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
36
300
1.20
0.46
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
36
300
1.20
0.46
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
36
300
1.20
0.46
1.2
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
7
49
1.43
0.46
1.1
1.2
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
7
49
1.43
0.46
1.7
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
210
1960
1.07
0.46
2.6
2.5
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
5
83
0.60
0.45
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
36
301
1.20
0.45
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
36
301
1.20
0.45
1.2
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
37
438
0.84
0.44
1.1
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
36
302
1.19
0.44
1.2
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
7
51
1.37
0.44
1.1
1.2
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
130
1414
0.92
0.43
1.7
1.6
nmol/l
0.7
0.5
0.32
111
1227
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
56
1.43
0.42
1.1
1.1
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
12
87
1.38
0.42
1.3
1.1
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
44
378
1.17
0.42
1.3
1.4
g/l
6.8
6.6
0.14
25
264
(3024139) IgG subclass 3 [Mass/volume] in Serum
44
378
1.17
0.42
1.2
1.4
g/l
0.4
0.4
0.15
24
263
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
36
304
1.19
0.41
2.3
2.7
au/ml
157.3
134.8
—
6
42
(1002224) Polysomnography panel
197
1844
1.07
0.41
1.1
1.1
—
—
—
0
0
(4062490)
44
379
1.16
0.41
1.3
1.4
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
44
379
1.16
0.41
1.3
1.4
g/l
3.6
3.0
0.86
25
266
(3019174) dRVVT (LA screen)
8
59
1.36
0.41
1.3
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
27
222
1.22
0.41
1.1
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
70
624
1.12
0.40
3.5
2.7
mg/l
22.0
23.4
0.12
53
383
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
25
204
1.23
0.40
1.1
1.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
17
216
0.79
0.40
1.0
1.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
13
171
0.76
0.39
1.2
1.6
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
5
35
1.43
0.39
1.6
1.7
—
—
—
0
0
(3027305) Fractional oxyhemoglobin in Arterial cord blood
0
19
0.00
0.39
0.0
1.1
—
36.6
—
0
19
(3034614) HLA Ag [Interpretation]
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
7
106
0.66
0.39
1.9
1.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
54
475
1.14
0.39
1.1
1.1
—
—
—
0
0
(3003633) Ovomucoid IgE Ab [Units/volume] in Serum
5
36
1.39
0.38
1.0
1.1
u/ml
0.0
9.8
—
5
31
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
120
1106
1.09
0.38
2.0
2.2
iu/l
3.4
4.3
1.28
47
465
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
12
89
1.35
0.37
1.2
1.2
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
37
317
1.17
0.37
3.0
3.5
mg/l
8.7
8.5
0.04
31
254
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
16
202
0.79
0.36
1.1
1.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
12
90
1.33
0.35
2.0
1.4
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
90
1.33
0.35
1.2
1.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
80
0.62
0.35
2.0
1.9
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
16
126
1.27
0.35
1.1
1.1
%
83.0
76.1
—
5
26
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
6
44
1.36
0.34
1.0
1.0
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
16
127
1.26
0.33
1.1
1.1
%
78.0
90.3
—
5
26
(3036048) Francisella tularensis Ab [Titer] in Serum
6
90
0.67
0.32
1.3
1.1
—
173.3
—
0
6
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
83
760
1.09
0.32
1.2
1.3
u/ml
41.3
32.5
—
10
64
(3047007) Chlamydophila sp Ab [Presence] in Serum
63
696
0.90
0.32
1.3
1.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
281
2688
1.05
0.31
1.5
1.4
u/l
8.4
7.4
0.87
231
2245
(3023430) Cat dander IgE Ab [Units/volume] in Serum
102
1101
0.92
0.31
1.1
1.1
u/ml
5.1
5.7
0.14
50
499
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
7
52
1.35
0.31
1.1
1.2
—
—
—
0
0
(4281824)
20
166
1.21
0.29
1.1
1.2
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
19
157
1.21
0.29
2.8
2.3
e6/l
205.5
190.4
0.08
11
77
(40768795) Lymph node Pathology biopsy report
23
194
1.19
0.29
1.4
1.2
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
12
94
1.28
0.28
2.0
1.4
—
—
—
0
0
(4094501)
29
333
0.87
0.27
1.0
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
80
865
0.92
0.27
2.1
2.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
128
1357
0.94
0.26
1.4
1.3
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
10
77
1.30
0.26
2.0
1.5
ug/l
8.1
7.9
—
10
77
(3024263) Appearance of Synovial fluid
9
76
1.18
0.24
1.6
3.4
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
35
391
0.89
0.23
1.1
1.0
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
17
143
1.19
0.23
1.5
1.4
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
11
136
0.81
0.23
1.2
1.3
u/l
177.6
186.4
0.44
11
136
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
33
294
1.12
0.23
1.1
1.1
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
5
39
1.28
0.23
1.2
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
5
40
1.25
0.22
1.4
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
47
514
0.91
0.22
1.3
1.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
57
526
1.08
0.21
1.2
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
30
336
0.89
0.21
1.2
1.2
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
11
0.00
0.21
0.0
3.3
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.1
—
211.5
—
0
11
(40768800) Prostate Pathology biopsy report
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3020911) Cortisol [Moles/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.1
—
116.5
—
0
11
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3004268) Protein electrophoresis panel - Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3025296) Carrot IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
6.0
—
0
5
(4133840)
16
135
1.19
0.21
1.1
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
96
905
1.06
0.21
2.4
1.8
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
12
0.00
0.21
0.0
1.0
—
3.5
—
0
12
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
98
1.23
0.21
2.0
1.4
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
12
145
0.83
0.21
1.2
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
111
1052
1.06
0.21
3.5
2.2
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
11
89
1.24
0.21
1.1
1.1
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
395
3849
1.03
0.20
1.7
1.6
mu/l
287.0
292.0
0.14
349
3446
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
159
1659
0.96
0.20
1.7
1.5
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
23
202
1.14
0.20
3.1
2.4
%
8.6
9.4
0.14
23
195
(40768793) Breast Pathology biopsy report
61
568
1.07
0.19
1.3
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
46
499
0.92
0.19
2.4
1.6
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
16
137
1.17
0.18
1.6
1.5
u/field
1.8
5.1
—
9
103
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
7
59
1.19
0.18
1.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
19
166
1.15
0.18
1.5
1.4
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
7
63
1.11
0.17
1.3
1.2
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
23
205
1.12
0.17
1.1
1.1
u/ml
0.5
7.4
1.18
16
127
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
257
2501
1.03
0.16
2.2
2.2
au/ml
9.5
18.8
2.91
18
230
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
152
1575
0.96
0.15
1.2
1.1
u/ml
3.4
1.4
1.05
75
689
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
9
78
1.15
0.15
1.0
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
36
332
1.09
0.15
1.1
1.1
u/l
1.0
1.0
0.01
14
126
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
34
314
1.08
0.14
1.2
1.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
117
1215
0.96
0.14
1.2
1.2
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
135
1396
0.97
0.13
1.1
1.1
u/ml
3.1
2.4
0.23
38
378
(4038314)
17
151
1.13
0.13
1.2
1.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
9
110
0.82
0.13
1.0
1.1
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
23
252
0.91
0.12
1.0
1.1
u/ml
10.4
7.4
—
6
33
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
10
85
1.18
0.12
1.1
1.2
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
13
147
0.88
0.11
1.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
13
147
0.88
0.11
1.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
13
147
0.88
0.11
1.0
1.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
13
147
0.88
0.11
1.1
1.1
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
17
153
1.11
0.11
1.6
1.9
u/field
1.4
2.5
—
9
86
(3043410) Blood group antigens tested for on Red Blood Cells
12
105
1.14
0.11
2.4
1.4
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
27
291
0.93
0.11
1.5
1.3
u/ml
0.4
0.8
0.51
13
85
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
10
86
1.16
0.11
4.7
3.4
u/ml
16.2
44.6
—
10
86
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
21
192
1.09
0.10
3.1
2.2
%
31.7
28.1
0.63
21
185
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
198
1936
1.02
0.10
1.8
1.5
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
239
2343
1.02
0.10
1.3
1.2
au/ml
32.9
38.0
—
5
73
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
212
2162
0.98
0.09
1.5
1.6
mg/l
4.7
3.4
1.20
150
1360
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
27
252
1.07
0.09
1.1
1.2
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
14
126
1.11
0.09
2.1
1.1
%
94.8
89.6
0.23
14
126
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
14
126
1.11
0.09
1.9
1.1
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
7
64
1.09
0.08
1.0
1.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
68
657
1.04
0.08
1.1
1.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
120
1229
0.98
0.08
1.4
1.5
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
7
67
1.04
0.08
1.4
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
63
652
0.97
0.07
2.3
1.8
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
23
215
1.07
0.07
1.0
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
48
499
0.96
0.07
1.0
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
13
118
1.10
0.07
1.2
1.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
306
3023
1.01
0.07
1.4
1.4
iu/l
13.9
11.8
0.73
243
2539
(3030313) Adrenal Ab [Titer] in Serum
8
91
0.88
0.06
1.0
1.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
136
1335
1.02
0.06
1.1
1.1
u/ml
1.9
1.3
0.20
72
613
(3020650) Glucose [Presence] in Urine
13
141
0.92
0.05
1.8
1.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
79
808
0.98
0.05
1.1
1.1
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
31
323
0.96
0.05
1.7
1.7
mmol/l
6.7
5.7
1.09
25
287
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
436
4389
0.99
0.04
1.5
1.6
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
17
180
0.94
0.04
7.2
8.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
10
92
1.09
0.03
1.5
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
38
371
1.02
0.02
5.2
2.3
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
41
401
1.02
0.02
3.7
4.4
u/ml
55.8
105.2
0.68
15
132
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
196
1949
1.01
0.01
1.6
1.6
%
19.5
23.8
0.82
17
221
(3024891) Influenza virus A+B Ag [Presence] in Specimen
130
1310
0.99
0.01
1.1
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
143
1420
1.01
0.01
1.1
1.1
u/ml
6.7
7.6
0.24
87
831
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
393
3918
1.00
0.01
1.3
1.2
iu/ml
186.3
147.3
0.94
138
1470
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
25
243
1.03
0.01
2.6
1.7
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
12
118
1.02
0.00
1.1
1.2
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
23
225
1.02
0.00
1.1
1.1
u/ml
22.0
10.5
—
9
50
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
90
902
1.00
0.00
1.6
1.6
mmol/l
6.5
6.4
0.20
61
628
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
12
116
1.03
0.00
1.6
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
134
0.97
0.00
1.1
1.2
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
89
893
1.00
0.00
1.1
1.1
u/ml
1.5
2.8
2.69
35
528
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
14
139
1.01
0.00
1.5
2.8
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
40
399
1.00
0.00
1.3
1.4
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
8
80
1.00
0.00
1.0
1.1
—
—
—
0
0
(3000219) Insulin receptor Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
3.5
—
—
—
0
0
(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3014178) Parietal cell Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042934) Triiodothyronine (T3) Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(36303858) Crystals [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
8
86
0.93
0.00
1.5
1.2
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045759) Histamine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021691) Plasmodium malariae Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
5
55
0.91
0.00
1.0
1.2
—
—
—
0
0
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.0
—
136.9
—
0
8
(3034092) Cytoplasmic Ig cells/100 cells in Blood
8
85
0.94
0.00
2.5
4.0
—
—
—
0
0
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3009992) Blasts/100 cells in Bone marrow
0
5
0.00
0.00
0.0
1.8
—
12.6
—
0
5
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
6
59
1.02
0.00
1.2
1.2
—
—
—
0
0
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
5
53
0.94
0.00
1.0
1.1
—
9.0
—
0
7
(4212803)
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027540) Rickettsia typhi Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
5
0.00
0.00
0.0
1.8
—
1132.3
—
0
5
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
9
0.00
0.00
0.0
1.1
—
9.0
—
0
9
(3000919) Neutrophils/100 leukocytes in Pleural fluid
0
9
0.00
0.00
0.0
1.1
—
53.8
—
0
9
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0

Mortality – FinRegistry

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

Index endpoint: K11_PARODON_OPER_EARLY – Parodontitis, under 40 years, or operation codes

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).